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Candida  albicans  exhibits  distinct  cytoprotective  responses  to  anti-fungal  drugs  that 
facilitate  the  evolution  of  drug  resistance 
 
Samira  Massahi  
 
Candida  albicans  is  both  a  human  commensal  and  opportunistic  pathogen.  Nosocomial 
infections  due  to  pathogenic C.  albicans  are  the  fourth  largest  in  North  America  and  carry 
significant  socioeconomic  burden.  Systemic Candida  infections  of  immune-compromised 
individuals  are  frequently  lethal  even  when  treated  optimally.  Drug  resistance  is  sometimes  due 
to  the  pre-existence  of  genetic  polymorphisms  that  bypass  the  mode  of  action  of  the  drug.  In 
other  cases,  resistance  is  acquired  via  the  evolution  of  genetic  polymorphisms.  There  is 
evidence  that C.  albicans  possesses  a  drug  tolerance  response  which  “buys  time”  for  individuals 
to  gain  such  beneficial  mutations.  Our  goal  is  to  characterize  this  poorly  understood  epigenetic 
cytoprotective  program  at  the  single  cell  molecular  level.  
Our  hypothesis  is  that  individuals  will  respond  differently  to  drug  exposure.  Some  will  not 
mount  a  sufficient  epigenetic  response  and  die,  while  others  will  survive  using  different 
pathways.  We  modified  a  single  cell  platform  for  the  fungal  setting  and  used  it  to 
transcriptionally  profile  thousands  of  treated  and  untreated  cells  at  early  (tolerance)  and  late 
(resistance)  timepoints.  Untreated  populations  exhibit  multivariate  epigenetic  responses  with 
individuals  partitioning  into  distinct  subpopulations,  each  with  a  unique  survival  strategy 
involving  efflux  pumps,  chaperones,  transport  mechanisms,  and  cell  wall  maintenance.  Cell 
imaging  will  be  used  to  validate  these  observations.  Whole  genome  DNA-sequencing  will  be 
used  to  determine  if  there  is  increased  instability  during  the  tolerance  phase.  Targeting  the 
tolerance  response  concomitantly  with  standard  therapies  could  represent  an  efficient  approach 
to  ablating  clinical  persistence. 
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Candida  albicans is  both  a  human  commensal  and  opportunistic  pathogen.  Nosocomial 
infections  due  to  pathogenic C.  albicans  are  the  fourth most  important  in  North  America  and  are  
associated  with  significant  socioeconomic  burden 1,2 .  Systemic Candida  infections  of 
immune-compromised  individuals  are  frequently  lethal  even  when  treated  optimally 3 .  
 
There  are  at  least  five  classes  of  anti-fungal  drugs:  the  polyenes,  the  azoles,  the  allylamines,  the 
echinocandins,  and  the  nucleoside  analog  flucytosine 4 .  The  first  four  attack  a  component  of  the 
pathogenic  fungi  that  is  distinct  from  the  human  host:  the  polyenes  cause  membrane  leakage 
through  interaction  with  ergosterol  whereas  the  azoles  and  allylamines  block  the  synthesis  of 
ergosterol  at  different  steps  and  the  echinocandins  attack  the  biosynthesis  of  the  fungal  cell  wall. 
Flucytosine  is  metabolized  into  compounds  that  interfere  with  fungal  DNA  replication  and  RNA 
production;  it  is  typically  used  in  combination  with  the  polyene  amphotericin  B.  
 
The  interaction  between C.  albicans and  antifungal  drugs  is  complex  and  multiple  factors 
determine  how  the  pathogen  will  be  cleared  or  persist  in  the  host  individual.  Persistence  may  be 
due  to  defects  in  the  immune  system  of  the  host 5,6  or  due  to  pre-existing  or  acquired  genetic  
mechanisms  of  resistance 7 .  For  example,  flucytosine  resistance  can  result  from  mutations  in  the 
cytosine  permease  leading  to  a  block  in  drug  uptake,  or  by  mutations  in  cytosine  deaminase  or 
uracil  phosphoribosyltransferase  that  prevent  the  compound  from  being  turned  into  a  toxic 
analog 8 .  Resistance  to  azoles  can  result  from  increased  drug  efflux 9–11  or  mutations  in  the  drug  
target ERG11 12 .  Similarly,  terbinafine  resistance  can  arise  from  mutations  in  the  drug  target 
squalene  epoxidase 13 ,  while  echinocandin  resistance  occurs  through  mutations  in  its  target,  the 
1-3  beta  glucan  synthase 14 .  Mutations  in  other  elements  can  influence  resistance  more  indirectly. 
For  example,  mutations  in  alternative  components  of  the  ergosterol  pathway  can  provide 
resistance  to  azoles  by  preventing  the  blocked  step  from  generating  the  highly  detrimental 
sterols  the  wild  type  cells  produce  when  Erg11  function  is  compromised 15 .  Stress  response 
pathways,  particularly  involving  Hsp90  circuitry,  are  also  linked  to  resistance  to  antifungal 
compounds 16 .  Importantly,  recent  unbiased  genomic  profiling  of  43  clinical  isolates  identified 
loss  of  heterozygosity  events  and  single  nucleotide  polymorphisms  in  over  240  genes  involved 
in  adherence,  filamentation,  virulence  and  other  processes,  suggesting  that  genetic  acquired 
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resistance  may  be  achieved  in  many  ways  including  via  genomic  instability 17–19 .  There  is  now  a 
substantial  literature  suggesting  that C.  albicans ,  like S.  cerevisiae ,  generate  large  scale 
genomic  variation  as  a  means  of  adaptation 20–25 ,  and  there  is  some  evidence  that  this  could  be 
facilitated  by  the  parasexuality  of  the  fungus 20,22,26–29 . 
 
C.  albicans is  well  adapted  to  its  role  as  an  opportunistic  pathogen  with  several  distinct  cellular 
morphologies  that  predominate  in  different  niches.  Drug  response,  resistance  and  clinical 
persistence  are  interwoven  with  these C.  albicans morphologies  including  the  white  yeast  form 
(round  smooth  cells)  implicated  in  bloodstream  dissemination,  the  opaque  yeast  form 
(rectangular  or  rod-shaped  cells  with  large  vacuoles)  found  predominantly  in  skin  infections 30 , 
and  the  hyphal  form  (filamentous  long  multifurcating  strands)  associated  with  tissue  invasion 31 . 
Each  morphology  has  unique  underlying  metabolic  and  regulatory  characteristics  that  play 
cytoprotective  roles  against  anti-fungals 32 .  Several  previous  efforts  have  performed  bulk 
RNA-sequencing  to  compare  white  opaque  and  filamentous 33–38 .  These  comparisons  produced 
lists  of  genes  that  were  differentially  expressed  (at  the  population  level)  between  each  two 
morphologies  under  different  growth  and  stress  conditions.  Such  a  list  of  genes  is  often  termed  a 
long-term  adaptive  transcriptional  signature ,  or  simply signature .  The  signatures  for  Candida 
morphologies  were  distinct:  although  sharing  many  genes,  each  signature  also  contains  many 
unique  genes  and  processes.  
 
Together,  these  molecular  and  cellular  processes  constitute  the  drug  tolerance  response,  a  short 
time  interval  post-treatment  that  is  inherently  epigenetic  in  nature,  involving  “reversible” 
regulatory  programs  and  an  absence  of  fixed  genetic  mutations.  That  is,  the  source  of  the  cells 
physiological  ability  to  survive  in  the  presence  of  the  inhibitory  compound  is  not  due  to  stable 
genomic  modifications,  but  rests  upon  post-transcriptional  programs  such  as  position  in  the  cell 
cycle,  expression  of  stress  genes,  or  random  fluctuation  in  key  cellular  defense  genes.  Even 
when  grown  under  standard  laboratory  conditions,  isogenetic  (or  near  isogenic) Candida 
populations  respond  differentially  to  antifungal  drugs,  with  some  fraction  of  the  population 
exhibiting  drug  tolerance,  defined  as  the  ability  of  individuals  to  survive  and  grow  at  drug 
concentrations  above  the  minimal  inhibitory  concentration  (MIC) 39,40 .  In  general,  tolerance  is  not 
nearly  as  well  understood  as  drug  resistance 41,42 .  Bet  hedging,  for  example,  in  response  to 
environmental  stress,  has  been  observed  in S.  cerevisiae 43,44 .  Tolerance  also  appears  to  be 
connected  with  reduced  drug  accumulation,  where  tolerant  cells  appear  physiologically  more 
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capable  of  preventing  drug  uptake  or  better  at  drug  export.  Although  time  scales  are  almost 
certainly  longer  within in  vivo contexts,  the  tolerance  phase,  defined  as  the  “lag  time”  between 
drug  introduction  and  true  acquired  resistance,  is  relatively  short;  in  some  cases  only  a  48hr 
window  is  sufficient  time  for  the  fixation  of  advantageous  genetic  lesions 20,22,39 . 
 
Taken  together  this  previous  work  suggests  that  the C.  albicans  drug  tolerance  response  “buys 
cells  time”  in  order  to  facilitate  the  appearance  of de  novo  genetic  mutations,  thus  increasing  the 
chance  of  long-term  survival.  However,  we  do  not  fully  understand  these  epigenetic  programs 
and  how  they  vary  between  drugs  and  environmental  conditions.  Our  effort  here  is  structured 
around  the  proposition  that  survival  of  any  individual C.  albicans  cell,  which  does  not  already 
harbour  a  latent  advantageous  genetic  mutation  conferring  drug  resistance, is  able  to  survive 
because  it  achieves  an  advantageous  epigenetic  configuration  at  the  time  of  the  drug  challenge. 
This  epigenetic  configure  provides  a  window  for  the  generation  of  somatic  mutational  events  for 
long-term  resistance  ( Figure  1A ). Previous  genomic  efforts  to  understand  tolerance  relied  on 
bulk  RNA-profiling,  however  in  this  case  the  transcriptional  profiles  describe  only  the  “average” 
expression  levels  for  each  gene  across  all  members  of  the  population.  Therefore,  they  were  not 
able  to  measure  perhaps  subtle  molecular  events  unique  to  individuals  or  small  subpopulations. 
With  bulk  profiling,  the  tolerance  response  would  need  to  be  near  universal,  common  across 
almost  all  members  of  the  colony.  The  work  discussed  in  the  previous  paragraph  suggests  that 
the  tolerance  response  is  not  the  same  across  all  survivors  in  a  population.  
 
Here  we  are  the  first  to  modify  a  single  cell  sequencing  approach  based  on  nano-litre  droplet 
sequencing  (DROP-seq)  for  the  fungal  setting.  DROP-seq  is  able  to  isolate  individual  cells  in  oil 
droplets,  lysis  the  cells,  capture  mRNAs  and  barcode  the  resultant  cDNA  for  next  generation 
sequencing.  Using  our  assay,  we  identify  sub  communities  that  successfully  tolerate  different 
anti-fungal  agents  with  distinct  modes  of  actions.  We  also  present  the  first  steps  towards  future 
investigations  of  single  cell  drug  response  dynamics  using  live  cell  imaging.  In  particular,  we 
show  how  we  will  validate  the  existence  of  our  subpopulations  using  fluorescent  tagged  genes. 
We  also  describe  our  first  steps  towards  understanding  if  and  how  our  distinct  subpopulations 
(defined  at  the  transcriptome  level)  are  characterized  at  the  genetic  DNA  level.  Specifically,  here 
since  an  isogenic  (or  near  isogenic)  SC5314  strain  was  used  in  our  study,  we  expect  that 
long-term  resistance  will  be  acquired  over  the  course  of  our  time  series.  Although  the  mRNAs 
captured  by  DROP-seq  provide  some  clues  as  to  what  the  nature  of  these  genetic  modifications, 
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more  thorough  large-scale  whole  genome  DNA  sequencing  would  allow  us  to  better  identify 
these  events,  especially  large  chromosome  amplifications  and  losses.  We  present  the  first  steps 
towards  investigating  the  same  populations  of  drug-challenged C.  albicans  at  the  genomic  DNA 
level.  We  argue  that  a  comprehensive  characterization  of  the  cytoprotective  molecular  pathways 
and  processes  could  lead  to  new  therapeutic  approaches  that  seek  to  ablate  the  tolerance 
















A  droplet-based  single  cell  sequencing  approach  for  fungi  (fungal  DROP-seq) 
The C.  albicans  setting  required  an  optimized  protocol  for  cell  preparation  with  specific 
techniques  to  remove  the  cell  wall  and  induce  stable  spheroplasts,  to  stabilize  and  protect 
cellular  RNA  in  situ (via  RNAlater,  a  non-toxic  reagent  that  rapidly  permeates  tissues  and  cells  in 
unfrozen  samples) ,  and  filtering  steps  to  separate  very  large  cells  with  hyphae  morphologies. 
SC5314, a  well  established  (circa  1984)  lab  grown  strain  (Squibb  Inc.) ,  were  grown  in  YPD 
media  alone  (untreated,  UT)  or  in  the  presence  of  an  antifungal  for  either  48  or  72  hrs  ( Methods 
2,  3 ).  We  chose  a  concentration  of 0.01  mg/ml  for  both  fluconazole  (FCZ)  and  nystatin  (NYS), 
representing  a  moderate  dosage  relative  to  their  MIC 50 s 
8,45–48 .  For  caspofungin  (CSP),  a 
compound  that  interrupts  cell  wall  biosynthesis 49–51 ,  a  concentration  of  1  nanogram/ml.  This  is 
well  below  its  MIC 50  levels  and  chosen  in  order  to  increase  the  number  of  survivors  of  this  
compound  ( Methods  3 ).  All  cultures  at  all  time  points  yielded  a  sufficient  population  of  survivors 
for  downstream  DROP-seq  profiling,  although  72  hr  Caspofungin  (CSP-72)  was  excluded  from 
the  present  study  for  logistical  difficulties.  In  particular,  we  were  able  to  recover  too  few  cells 
from  the  culture  due  to  adherence  between  intact  cell  walls  (the  colony  will  be  revisited  when  all 
samples  are  re-processed).  The  cells  were  processed  with  our  fungal  DROP-seq  device,  and 
the  captured  material  sequenced  with Illumina  NEXT-seq  following  a  standard  protocol 52,53  with  
~200M  read/sample ( Methods  4-6 ) .  The  raw  sequencing  data  was  subjected  to  our 
bioinformatics  pipeline  for  read  processing,  data  normalization  and  imputation  ( Methods  7 ). 
Figure  1B,  C  and Supplemental  Figure  1  provide  summaries  of  the  observed  data 
post-sequencing,  and  the  effects  of  normalization  and  imputation  respectively. Results  are 







Different  anti-fungals  exhibit  distinct  transcriptional  responses 
We  asked  whether C.  albicans  populations  exhibit  distinct  responses  to  different  anti-fungal 
drugs. Figure  2 provides  an  unsupervised  clustering  of  the  single  cell  expression  profiles 
(UMAP, Methods  8 )  labelled  with  population  of  origin  (panel  A )  .  UMAP  is  a  type  of  clustering 
that  maps  the  expression  profiles  of  cells  to  a  manifold,  a  multidimensional  nonlinear  surface. 
The  idea  is  that  cells  with  similar  expression  profiles  will  reside  close  to  one  another  on  this 
manifold  than  cells  that  are  not  similar  will  be  more  distant.  Then  UMAP  projects  this 
multidimensional  nonlinear  surface  to  two  dimensions  for  visualization.  As  such,  the  x  and  y 
units  are  unitless  and  it  is  dangerous  to  place  too  much  meaning  in  large  versus  small  gaps 
between  disconnected  clusters.  This  is  because  we  are  transforming  high  dimensional  data  (the 
expression  of  thousands  of  genes  over  thousands  of  cells)  onto  two  dimen,sions.  Alternative 
dimensionality  reduction  techniques  and  visualizations 54,55  produced  qualitatively  similar  cell  
clusters  (data  not  shown).  Then  after  the  UMAP  embedding  in  two  dimensions  is  established, 
we  use  Louvain  clustering  in  the  VISION  package  (panel  B )  to  fracture  this  space  into  disjoint 
gene  expression  patterns.  Like  most  classic  clustering  techniques,  the  number  of  clusters  is  a 
controllable  parameter. 
 
Although  UT  cells  are  likely  near  isogenic,  they  exhibit  considerable  transcriptional  variation, 
bridging  from  some  late  FCZ-72  survivors  (cluster  14)  to  late  NYS-72  survivors  (cluster  1). 
FCZ-72  and  NYS-72  survivors  have  distinct  gene  expression  patterns,  each  separating  into  two 
non-overlapping  clusters.  One  subpopulation  of  CSP-48  and  a  subpopulation  FCZ-48  are  highly 
intermixed  in  clusters  9,  16,  18  and  20  (panel  B ).  Far  from  this  location,  a  second  pair  of 
subpopulations  of  CSP-48  and  FCZ-48  form  cluster  6.  In  fact,  cluster  6  contains  cells  from 
almost  all  drugs  and  timepoints. 
 
We  next  investigated  whether  specific  processes  and  pathways  were  differential  between  the 
subpopulations  highlighted  in  panels A  and B .  Towards  this  end,  we  collected  from  the  literature 
genes  or  transcriptional  signatures  for  relevant  biological  processes  ( Methods  9 ),  and 
summarized  the  joint  expression  pattern  of  this  set  of  genes  for  each  cell  using  VISION 
( Methods  10 ).  Drug  resistance  genes  including  those  coding  for  efflux  pumps  were  generally 
expressed  lowest  in  UT  cells (Figure  2C)  as  perhaps  expected.  Moreover,  UT  cells  had  the 
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most  evidence  of  expressing  the  white  yeast  morphology  and  the  least  evidence  of  hyphae 
transcriptional  signatures,  compared  to  drug  treated  populations  ( Figure  2D ).  Nevertheless, C. 
albicans  cell  microscopy  did  not  show  as  many  hyphae/pseudohyphae  morphologies  as  our 
data  suggested  ( Supplemental  Figures  3  and  4 ).  
 
Many  of  the  genes  differentially  expressed  between  UT  and  all  drug  treated  populations  were 
related  to  cellular  morphology  including PFY1  (1.5  logFC), WH11  (1.77), PST1  (2.0).  Also 
supporting  the  quality  of  our  data,  we  observed  that  the  inducible  Environmental  Stress 
Response  (iESR) 56,57 ,  a  signature  that  should  be  upregulated  in  stressed  cells,  varied 
significantly  across  our  panel  and  was  inversely  correlated  with  the  expression  of  ribosomal 
proteins,  which  tend  to  be  expressed  higher  in  stable  healthy  cells 56  ( Figure  2E,  F ).  This  
suggests  that  the  single  cell  approach  is  able  to  detect  differences  that  bulk  profiling  was  unable 
to  find.  We  were  able  to  verify  that  the  clusters  from  Panel B  are  not  primarily  driven  by  cell 
cycle  state  ( Supplemental Figure  1,  Methods  9 ).  Overall,  we  observe  a  varied  response  for 
many  additional  processes  ( Figure  2G ).  Together  this  suggests  that C.  albicans  mounts  distinct 
molecular  responses  to  different  classes  of  anti-fungal  drugs. 
 
Untreated  colonies  exhibit  significant  heterogeneity  
We  also  observed  from Figure  2  that  there  is  significant  transcriptional  heterogeneity  across  UT 
cells  involving  at  least  seven  VISION  clusters  ( Panel  B ).  Of  particular  note,  mustard  cluster  6  is 
diverse,  containing  UT  cells  and  cells  from  all  drug/time  points.  Dark  blue  cluster  1  is  intermixed 
with  late  NYS-72  survivors.  Some  remaining  UT  cells  border  late  FCZ-72  survivors.  
 
In  order  to  better  characterize  molecular  differences  here,  we  restricted  attention  to  only  UT 
cells,  applied  Louvain  clustering  and  identified  15  distinct  transcriptional  regions  ( Figure  3A ). 
Three  regions  (cluster  8  versus  cluster  12  versus  clusters  2,  4  and  10)  express  the  iESR;  this 
signature  is  broadly  anti-correlated  with  the  ribosomal  protein  (RP)  signature,  which  is  generally 
considered  a  signature  of  healthy  cells  ( Figure  3B ).  Our  goal  was  then  to  characterize  these 
three  regions  across  our  panel  of  signatures  ( Figure  3E ).  Cluster  8  strongly  expresses  most 
signatures  except  ergosterol  and  cell  maintenance,  suggesting  the  cells  are  very  active  although 
grown  in  an  untreated  environment  with  sufficient  media, which  was  unexpected  considering 
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these  cells  were  not  challenged  by  stressful  situations .  Cluster  12  most  strongly  expressed  the 
cell  maintenance  and  efflux  pump  signatures,  but  with  moderate  fluctuation  in  the  remaining 
pathways.  The  regions  defined  by  clusters  2,  4  and  10  are  largely  characterized  by  an  absence, 
or  possibly  repression,  of  expression  across  most  molecular  processes,  suggesting  these  cells 
are  healthy.  
 
At  the  gene  level,  we  observe  expression  of  the  endoplasmic  reticulum  chaperone  HSP70 
localized  to  cluster  8,  the  ABC  transporter PRN3  localized  to  cluster  12,  and TTR1 ,  a  dithiol 
glutaredoxin,  is  most  highly  expressed  in  clusters  2,  4  and  10  ( Figure  3C ).  We  located  these  UT 
cells  which  express  markers HSP70 , PRN3  or TTR1  back  in  the  UMAP  embedding  for  all  cell 
populations  ( Figure  3D ). HSP70  is  most  highly  expressed  in  mustard  cluster  6  of Figure  2B ,  a 
highly  diverse  clustering  containing  UT  cells  and  cells  from  each  drug  exposure.  We  asked  what 
genes  were  strongly  differentially  expressed  between these  clusters  and remaining  cells 
( Supplemental  Table  3) and found  that  many  have  well  established  roles  in  different  stress 
responses  including HSP21 , HGT6  and CAS5  in  the  core  stress  response, GAC1,  XYL2  and 
ADH2  in  acid  stress, SOD3,  YCF1  and OXR1  in  oxidative  stress,  consistent  with  the  high 
expression  of  the  iESR  signature  in  this  cluster  ( Figure  2E ).  Other  genes  are  known  hyphae 
morphology  related  genes  including YHB1,  UCF1,  XYL2,  FAB1  and REG1 ,  or  genes  with 
established  roles  in  virulence  including  HSP21  and  YHB1 .  
 
PRN3  is  mostly  highly  expressed  in  dark  blue  cluster  1  of Figure  2B ,  a  cluster  enriched  for  late 
NYS-72  survivors.  We  asked  what  genes  were  strongly  differentially  expressed  between these 
dark  blue  cluster  1  of Figure  2B  and  neighbouring  UT  cells  of  cluster  11,  and  identified  several 
genes  with  established  roles  in  drug  resistance  (eg RPL24,  FMP45,  ERG25 ),  biofilm  formation 
(eg TY37 ),  and  cell  wall  maintenance  (eg PGA31 )  ( Supplemental  Table  4 ).  High  iESR 
expression  was  also  detected  in  this  cluster. TTR1  is  most  highly  expressed  in  the  mustard 
cluster  6  (where HSP70  is  expressed)  but  also  uniquely  expressed  in  the  clusters  predominated 
by  UT  cells  (2,4,5,11,14)  of Figure  2B .  There  was  in  general  little  evidence  of  expression  of  the 
iESR  in  these  clusters. 
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Together  the  data  supports  the  existence  of  three  distinct  subpopulations  of  UT  cells,  and 
provides  preliminary  evidence  that  these  subpopulations  expressed  different  transcriptional 
programs.  This  includes,  but  is  not  limited  to,  variability  in  iESR  expression  levels. The fact  that 
high  iESR  expressing  UT  cells  co-cluster  with  late  FCZ-72  and  NYS-72  survivors  is  consistent 
with  the  concept  that  a  cell  which  “bet  hedges”  is  more  likely  to  survive. 
 
To  confirm  the  presence  of  the  different  subpopulations  of  UT  cells,  we  are  building  genetically 
modified C.  albicans  strains  that  harbour GFP -  and RFP -tagged  Hsp70  and  Ttr1  proteins 
respectively  ( Methods  11a-c,  Supplemental  Table  1 ).  The  resultant  transformed  fluorescence 
proteins  represent  fusion  proteins  and  not C.  albicans  gene  replacement  by  the GFP  or RFP .  At 
present,  we  have  successfully  completed  the  single  RFP-Ttr1  strain,  which  is  now  frozen  down 
in  response  to  COVID-19  ( Supplemental  Figure  5 ).  When  we  are  able,  we  will  complete  the 
construction  of  the  double  mutant  with GFP -tagged  Hsp70,  and  grow  UT  cells  in  the  same 
manner  as  for  single  cell  sequencing  ( Methods  3 ).  The  colonies  will  then  be  subjected  to  live 
cell  fluorescent  imaging  ( Methods  11d )  to  test  for  the  presence  of  two  distinct  non-overlapping 
sub-populations  of  cells. 
  
Two  distinct  subpopulations  are  observed  during  the  tolerance  phase  after  treatment  with 
fluconazole 
Figure  2A  suggests  that  isogenic  (or  near  isogenic)  individuals  respond  differentially  to  the 
same  challenge.  In  particular,  there  are  two  distinct  subpopulations  of  FCZ-48  survivors:  clusters 
9,  16,  18,  20  versus  the  second  subpopulation  in  mustard  cluster  6  ( Figure  2B ).  To  better 
characterize  the  molecular  differences  between  the  two  subpopulations,  we  restricted  attention 
to  only  FCZ-48  cells  and  applied  Louvain  clustering  ( Figure  4A) . The  FCZ-48  cells  in  the  brown 
and  pink  clusters  6  and  7  map  exclusively  to  the  highly  diverse  mustard  cluster  6  of Figure  2B 
discussed  previously.  We  refer  to  these  two  clusters  as  Response  A,  and  the  remaining  clusters 




Response  A  shows  higher  expression  for  most  pathways  ( Figure  4E )  including  mechanisms 
established  in  the  literature 11,12,45,59  as  important  to  fluconazole  resistance  including  cell  
membrane,  oxidative  stress  and  ergosterol  pathway  members  ( Figure  4C ).  
 
We  hypothesized  that  cells  exhibiting  response  A  are  more  likely  to  survive  to  72  hours.  To  test 
this  hypothesis,  we  selected  markers UCF1  and CMD1  that  are  strongly  differentially  expressed 
between  response  A  and  B  ( Figure  4D ).  UCF1  (Up-regulated  by  CAMP  in  Filamentous  growth 
1)  exhibits  higher  expression  in  Response  A.  Consistent  with  our  hypothesis,  down-regulation  of 
UCF1  is  associated  with  resistance  to  FCZ.  Ca2+  binding  protein CMD1  (Calmodulin)  regulates 
many  Ca2+  independent  processes  related  to  cellular  morphology,  growth  and  mitosis.  It  is  not 
expressed  in  Response  A  and  shows  variable  expression  across  Response  B.  
 
To  confirm  the  presence  of  two  different  subpopulations  in  FCZ-48  populations,  we  are  building 
genetically  modified C.  albicans  strains  that  harbour GFP -  and RFP -tagged  for  Ucf1  and  for 
Cmd1  proteins  respectively  ( Methods  11a-c,  Supplemental  Table  1 ).  These  two  genes  are 
each  expressed  in  two  different C  albicans  subpopulations  48hrs  post  FCZ  treatment.  There  is 
no  evidence  of  any  FCZ-48  survivors  that  express  both  genes  simultaneously.  Therefore,  we 
transform  both  genes  with  GFP  and  RFP  to  emit  different  fluorescent  signals,  we  expect  to  see 
two  visible  non-overlapping  subpopulations  at  48  hours.  Our  hope  is  that  expression  at  the 
transcriptional  level  will  be  well  correlated  with  protein  fluorescence.  We  can  also  follow  our  FP 
cells  from  drug  treatment  to  48hrs  to  72  hrs  and  beyond.  This  will  provide  evidence  of  whether 
both  subpopulations  (one  defined  by  the  presence  of  Ucf1  and  absence  of  Cmd1,  one  defined 
by  the  absence  of  Uc1  and  the  presence  of  Cmd1)  contribute  survivors  to  later  time  points.  In 
summary,  the  single  cell  expression  profiles  identify  novel  subpopulations  and  the  microscopy 
allows  us  to  “link”  these  subpopulations  over  time  along  the  path  from  tolerance  to  resistance. 
 
At  present,  we  have  successfully  completed  the  single RFP  Cmd1  strain,  which  is  now  frozen 
down  in  response  to  COVID-19  ( Supplemental  Figure  5 ).  When  we  are  able,  we  will  complete 
the  construction  of  the  double  mutant  with GFP -tagged  Ucf1,  and  grow  FCZ-48  cells  in  the  same 
manner  as  for  single  cell  sequencing  ( Methods  3 ).  The  colonies  will  then  be  subjected  to  live 
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cell  fluorescent  imaging  ( Methods  11d )  to  test  for  the  presence  of  two  distinct  non-overlapping 
sub-populations  of  cells.  
 
We  note  that  CSP-48  survivors  intermix  with  the  FCZ-48  survivors  in  both  response  A  and  B, 
suggesting  that  although  caspofungin  and  fluconazole  are  different  classes  of  anti-fungals  with 
distinct  modes  of  action,  patterns  of  heterogeneity  are  conserved.  We  will  use  the  genetically 
modified C.  albicans  strains  with GFP -tagged  Ucf1  and RFP -tagged  Cmd1,  but  this  time 
exposed  the  population  to  CSP-48  at  the  same  concentration  levels  as  was  used  for  single  cell 
sequencing. This  experiment,  which  was  interrupted  will  resume  when  the  COVID-19  lockdown 
ends. 
 
There  is  little  evidence  of  multiple  subpopulations  across  NYS-48  survivors  with  the  vast  majority 
of  cells  restricted  to  response  A.  Since  our  cell  membrane  signature  is  much  higher  expressed  in 
Response  A  compared  to  B,  we  conjecture  that  cells  that  lowly  express  this  process  are  highly 
sensitive  to  nystatin  treatment  as  it  specifically  disrupts  membrane  function. 
 
Two  distinct  subpopulations  are  observed  in  late  72  hours  survivors  after  treatment  with 
fluconazole 
Figure  2A  suggests  that  late  72  hour  survivors  of  fluconazole  treatment  partition  into  two  distinct 
subpopulations.  The  first  population  resides  at  the  convergence  of  clusters  3,  11  and  14,  and 
overlap  with  outlier  UT  cells  ( Figure  2B ).  The  second  population  is  contained  exclusively  within 
cluster  7,  and  resides  in  close  proximity  to  Response  A  observed  at  the  48  hour  time  point. 
UMAP-based  visualizations  of  FCZ-72  identify  two  main  subpopulations  (clusters  2  and  7  versus 
the  remaining  eight  clusters; Figure  5A ).  Cells  from  clusters  2  and  7  correspond  exclusively  to 
Response  A  and  the  remainder  to  Response  B  ( Figure  5C ).  The  pathways  and  processes 
differentially  expressed  between  these  two  subpopulations  share  many  similarities  to  the 
observations  made  in  the  context  of  48  hour  post-FCZ  treatment  ( Figure  5B ).  
 
We  observe  however  that  the  FCZ-72  population  closest  to  Response  B  has  shifted  slightly 
towards  the  expression  profiles  of  UT  in  comparison  to  the  FCZ-48  Response  B  cells  ( Figure 
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2A ).  We  searched  our  signatures  for  those  whose  expression  at  72  hours  more  closely 
resembled  UT  cells,  in  comparison  to  early  48  hour  treatment.  Both  the  ergosterol  and  efflux 
pathways  were  more  lowly  expressed  in  both  FCZ-72  and  UT  cells  than  in  FCZ-48.  Conversely, 
stress  pathways  including  oxidative  stress,  heat  shock  and  the  iESR  are  more  highly  expressed 
in  the  FCZ-72  and  UT  cells  than  in  FCZ-48  ( Figure  5D ).  In  general,  the  expression  changes 
associated  with  Response  B  are  difficult  to  interpret;  however  they  do  suggest  the  tolerance 
phase  at  48  hours  may  be  stochastically  probing  different  combinations  of  responses  to  survive, 
and  survival  of  these  cells,  even  if  it  is  less  likely  than  Response  A,  may  involve  the  ablation  of 
unnecessary  cytoprotective  pathways. 
 
To  examine  the  dynamics  of  these  subpopulations  from  untreated,  through  the  tolerance  phase 
to  late  survivors  at  72  hours,  we  selected  two  markers WH11  and YHB1  that  showed  differential 
expression  between  the  two  responses  and  variability  across  the  time  points  ( Figure  6A,B ). 
WH11  is  expressed  specifically  in  white-phase  yeast-form  cells  and  is  similar  in  structure  to  S. 
cerevisiae GLP1 ,  a  gene  coding  for  a  plasma  membrane  protein  involved  in  membrane 
organization  and  involved  in  maintaining  organization  during  stress  conditions. WH11  is  strongly 
expressed  in  almost  all  UT  cells  (both  in  Response  A  and  B),  loses  expression  in  FCZ-48  but 
regains  expression  in  FCZ-72  in  Response  B.  The  nitric  oxide  dioxygenase YHB1  is  only 
expressed  in  cells  occurring  in  Response  A  at  all  time  points  UT,  FCZ-48  and  FCZ-72.  
 
To  confirm  the  presence  of  two  different  subpopulations  in  FCZ-72  populations,  we  again  are 
creating  double  genetic  mutant  strains  contain  fluorescent  markers  for  both  Wh11  (RFP)  and 
Yhb1  ( GFP )  ( Methods  11a-c,  Supplemental  Table  1,  Supplemental  Figure  5 ).  At  present,  we 
have  successfully  completed  the  single RFP  Wh11  strain,  which  is  now  frozen  down  in  response 
to  covid-19  ( Supplemental  Figure  5 ).  When  we  are  able,  we  will  complete  the  construction  of 
the  double  mutant  with GFP -tagged  Yhb1,  and  grow  FCZ-72  cells  in  the  same  manner  as  for 
single  cell  sequencing  ( Methods  3 ).  The  colonies  will  then  be  subjected  to  live  cell  fluorescent 
imaging  ( Methods  11d )  to  test  for  the  presence  of  two  distinct  non-overlapping  sub-populations 




Two  distinct  subpopulations  are  observed  in  late  72  hours  survivors  after  treatment  with 
nystatin 
Late  surviving  NYS-72  cells  exhibited  evidence  of  transcriptional  heterogeneity  with  two 
subpopulations  consisting  of  cluster  6  or  clusters  1,  17,  and  19  in Figure  2B .  Both 
subpopulations  are  contained  in  our  so-called  Response  A.  Due  to  technical  reasons  the 
NYS-48  profiles  produced  fewer  than  expected  cells,  although  these  same  two  Response  A 
subpopulations  are  also  observed  during  the  tolerance  phase. 
 
Figure  7A  depicts  the  relationships  between  just  NYS-72  cells.  Here,  green  toned  clusters  8  and 
9  correspond  to  the  cluster  6  in Figure  2B ,  a  highly  diverse  cluster  that  contains  cells  from  all 
populations.  Although  there  is  no  difference  in  expression  of  the  iESR  or  ribosomal  protein  (RP) 
signatures,  expression  of  the  white,  heat  shock  proteins  (HSP),  oxidative,  iron  stress  and 
membrane  signatures  are  all  localized  to  cluster  6  ( Figure  7B-E ).  
Since UCF1  is  expressed  exclusively  in  cluster  6,  we  will  also  use  our GFP -tagged C.  albicans 
to  observe  cell  growth  in  the  presence  of  NYS.  
 
DNA  level  investigations  of  drug  tolerance  and  resistance 
We  sought  to  further  investigate  the  findings  obtained  from  single  cell  transcriptomic  and 
phenotypic  data  at  the  DNA  level.  In  particular,  we  are  interested  in  understanding  if  and  how  an 
isogenic  (or  near  isogenic)  founder  population  can  generate  genetic  polymorphisms  that  incur 
long  time  “true”  genetic  drug  resistance.  As  reviewed  above,  there  is  evidence  for  such  dynamic 
processes  during  the  tolerance  phase  including  the  whole  genome  DNA  profiling  of  Ford  et  al. 
with  clinical  isolates  of C.  albicans 60 .  Importantly,  Ford  et  al.  are  able  to  argue  that  specific 
chromosomal  amplifications,  polymorphisms  and  loss  of  heterozygosity  (LOH)  events  are 
persistent,  statistically  over-represented  and  recurring.  Rosenberg  et  al. 42  also  showed  that de  
novo  genomic  modifications  occurred  after  challenging C.  albicans  with  drugs  after  just  48 
hours.  
 
We  grew  C.  albicans  colonies  in  an  identical  manner  as  for  the  single  cell  transcriptomics  except 
we  included  two  additional  later  time  points  at  6  and  12  days  ( Methods  2,  3  and  12a ).  As  it 
remains  too  costly  to  sequence  full  genomes  at  the  single  cell  level,  we  extracted  genomic  DNA 
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(gDNA)  of  each  colony  in  bulk  and  prepared  it  for  Illumina-based  next  generation  sequencing 
( Methods  12b ).  Careful  analysis  and  previous  efforts 17,18  converged  on  a  recommended  depth  
of  100  fold  DNA  coverage.  The  gDNA  samples  passed  quality  control  criteria  ( Supplemental 
Figures  6-9 )  and  were  sent  for  sequencing,  but  were  halted  due  to  the  COVID-19  lockdown. 
The  computational  pipeline  is  in  place  ( Methods  12c ).  As  these  DNA  profiles  are  bulk  and  not 
single  cell,  the  computational  challenge  will  be  to  “align”  as  best  possible  the  observed 
frequencies  of  events  with  the  relative  size  of  subpopulations  as  observed  by  single  cell 
transcriptomics  and  microscopy,  and  to  identify  driver  genes  within  regions  of  chromosomal 
aberrations.  We  anticipate  that  we  will  be  able  to  identify  candidate  genomic  loci  that  are 
markers  of  each  subpopulation  across  the  time  points  and  drug  conditions;  these  markers  can 
then  be  evaluated  by  alternative  methods  such  as  fluorescence  in  situ  hybridization  (FISH).  This 
method  would  allow  us  to  identify  these  genetic  events  in  the  context  of  our  single  cell 























C.  albicans  SC5314  populations,  either  untreated  or  grown  in  the  presence  of  one  of  three 
anti-fungals,  were  transcriptionally  profiled  using  a  nano-litre  droplet-based  single  cell 
sequencing  approach  optimized  for  the  fungal  setting.  The  untreated  population  is  likely  isogenic 
or  near  isogenic,  thereby  minimizing  the  chance  for  preexisting  genetic  polymorphisms  that 
confers  resistance.  In  terms  of Figure  1A ,  the  untreated  population  before  t 0  is  green  only.  In  
support  of  this,  we  observe  heterogeneity  in  gene  expression  across  the  untreated  population 
but  do  not  observe  distinct  subpopulations  with  clear  boundaries  ( Figure  2A ),  with  perhaps  the 
exception  of  a  few  cells  that  belong  to  the  mustard  colored  cluster  6  of Figure  2B .  Some  but  not 
all  of  this  variability  is  explained  by  variation  in  cell  cycle.  In  fact,  over  the  15  clusters  found 
computationally  across  this  population,  many  different  processes  show  differential  expression 
including  the  induced  environmental  stress  response  (iESR),  ribosomal  proteins  (RP)  and  other 
processes  linked  to  drug  response/stress  including  efflux  pumps.  In  general,  untreated  cells 
expressing  the  iESR  fall  at  the  edges  of  the  untreated  cloud  and  inter-mix  with  late  survivors 
challenged  by  anti-fungals.  Our  DNA  sequencing  effort,  when  it  resumes  post-lockdown,  will 
allow  us  to  better  estimate  how  truly  isogenic  the  founder  population  is  in  our  experiments.  
 
Microscopy  confirms  that  the  vast  majority  (>99%)  of  the  cells  in  the  untreated  populations  are  of 
the  white  yeast  morphology,  however  gene  expression  signatures  for  early  germ  bud  and  late 
hyphae  stages  do  show  variability.  We  conjecture  that  is  at  least  in  part  due  to  limitations  in  the 
way  that  these  signatures  from  the  literature  were  formed.  That  is,  methodology  from  previous 
studies  used  supervised  analysis  of  gene  expression  profiles  between  white  yeast  and  other 
morphologies  in  bulk  populations.  Such  bulk-derived  lists  of  genes  may  not  be  sufficiently  robust 
to  capture  a  presumably  multi-step  trajectory  between  the  target  morphologies.  This  is  an 
example  of  Simpson’s  paradox 61 .  We  conjecture  that  even  healthy  cells  cycle  through  regulatory 
programs  that  represent  proto-opaque,  budding  or  filamentous  morphologies.  In  other  words, 
healthy  cells  “bet  hedge”  with  various  stress  responses  including  an  inclination  towards  a 
change  in  morphology.  The  most  extreme  example  of  this  are  those  untreated  cells  that  fall 
within  mustard  cluster  6  of Figure  2B .  These  are  very  active  cells  expressing  many  pathways 
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simultaneously.  We  conjecture  that  untreated  cells  in  the  core  or  upper  region  of Figure  2A  do 
not  successfully  transition  to  the  tolerance  phase  ( Figure  1A ,  green  region  B).  
 
Each  drug  challenged  population  was  profiled  after  48  hours,  a  latency  chosen  to  provide 
sufficient  time  for  the  drug  to  influence  the  colony  but  too  short  to  allow  genetic  adaptation  and 
resistance.  Survivors  profiled  at  48hrs  under  both  fluconazole  and  caspofungin  largely  partition 
into  two  subpopulations,  which  we  have  termed  response  A  and  B  throughout  this  manuscript.  In 
broad  terms,  cells  exhibiting  response  A  appear  transcriptionally  active,  expressing  many  stress 
and  maintenance  pathways  including  the  proto-filamentous  signatures  described  above.  This 
latter  statement  is  supported  by  microscopy  of  the  populations  that  establish  a  higher  fraction  of 
filamentous  cells  in  response  A  compared  to  response  B.  When  we  resume  post-covid-19 
lockdown,  our  genetically  modified C.  albicans  strains  expressing  fluorescent  reporters  will  allow 
us  to  determine  whether  or  not  both  response  A  and  B  at  48  hours  contribute  cells  that  survive 
to  72  hours.  If  so,  this  would  suggest  that  cells  have  distinct  survival  paths.  Perhaps  response  A 
represents  an  aggressive tour  de  force  while  response  B  represents  a  more  passive  cell  arrest 
strategy.  
 
In  fact,  the  fluconazole  and  caspofungin  populations  intermix  in  both  response  A  and  B,  even 
though  they  represent  two  distinct  classes  of  antifungals  with  different  modes  of  action 
(disrupting  ergosterol  versus  cell  wall  biosynthesis),  suggesting  that  cells  choose  a  survival  path 
that  is  in  some  cases  independent  of  the  specific  drug.  We  are  currently  investigating  whether 
this  bimodal  response  is  maintained  for  other  -azoles  and  other  -fungins  including  additional 
drugs  representative  of  all  five  classes  of  anti-fungals. 
 
Our  data  suggests  that  72  hour  survivors,  which  have  presumably  had  sufficient  time  to  develop 
genetic  resistance,  originate  from  both  A  and  B  responses  at  48  hours.  This  is  apparent  from  the 
single  cell  transcriptomics-based  clustering.  Our  double  genetic  mutants  with  live  cell  imaging 
experiments  post-lockdown  will  provide  more  insight  into  this  phenomena.  Given  that  response 
A  individuals  are  more  active  transcriptionally,  we  would  conjecture  that  this  response  is 
enriched  for  individuals  with  acquired  genetic  resistance  (yellow  type  of Figure  1A )  with 
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response  B  relatively  enriched  perhaps  for  individuals  who  solely  exploited  epigenetic  regulatory 
programs  to  survive  the  chemical  insult  (orange  type  of Figure  1A ). We  are  also  currently 
conducting  experiments  with  pulse  drug  delivery  to  better  ablate  cell  escape  simply  due  to  better 
guarantee  the  population  is  continually  challenged  to  evolve  resistance  following  Cowen  and 
colleagues 62 .  We  are  also  exploring  a  greater  range  of  concentrations  including  the  MIC 25, and 
MPC  (Mutant  Prevention  Concentration) 63  following  EUCAST  guidelines  ( www.eucast.org ).  In  
particular,  we  are  extending  our  time  series  with  DROP-seq  to  6  and  12  days  with  a  re-pulse  of 
drug  and  fresh  media  at  3  and  9  days. 
 
We  are  currently  revisiting  the  concentrations  of  lysis  buffer  and  zymolyase  in  the  protocol  in 
order  to  increase  mRNA  yield  during  the  DROP-seq  step (Methods  4  and  5). We  are  in  the 
process  of  re-running  all  drugs  and  timepoints  in  order  to  address  issues  of  reproducibility,  batch 
effect,  statistical  power 64  and  correct  technical  problems  related  to  nystatin  and  caspofungin  in  
the  first  round  of  profiles.  This  new  set  of  experiments  will  also  extend  our  repertoire  of  drugs  to 
amphotericin  B,  flucytosine  and  rapamycin,  and  to  a  new  media  sorbose,  which  was  previously 
confirmed  to  have  a  role  in  causing  genome  instability  in  C.albicans 19 .  
 
Our  focus  now  has  strongly  shifted  towards  combining  the  transcriptomic  data  with  whole 
genome  DNA  sequencing  to  identify  plausible  molecular  mechanisms  for  rapid  evolution 
perhaps  based  on  genomic  neoplasticity  and  instability 20–24,26,27 .  The  ability  to  identify  genetic 
polymorphisms  including  large-scale  chromosomal  aberrations  that  are  specific  to 
subpopulations  may  provide  insight  into  general  mechanisms  exploited  by C.  albicans  during  the 
tolerance  phase  in  order  to  “try  out”  many  combinations  of  responses  perhaps  not  unlike  how 
genomic  instability  and  neoplasticity  drive  innovation  in  tumors. 
 
This  additional  data  at  both  the  DNA  and  mRNA  levels  will  allow  us  to  move  towards  fuller 
pseudotime  trajectories 65–72 ,  a  common  powerful  approach  in  single  cell  studies,  that 
frame-by-frame  track  changes  from  untreated  through  tolerant  to  resistant  cells.  The  number  of 
cells  per  sample  and  the  number  of  distinct  transcripts  harvested  per  cell  are  two  factors  that 
have  been  challenged  for  pseudotime  reconstructions.  However,  conceptually  a  more  difficult 
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challenge  lies  in  the  fact  that  expression  profiles  of  72  hour  survivors  (perhaps  not  surprisingly) 
map  closer  to  untreated  cells  than  48  hour  tolerance  cells.  This  is  in  part,  but  not  exclusively, 
due  to  the  fact  that  the  induced  environmental  stress  response  involves  several  hundred  genes, 
and  it  is  most  strongly  expressed  in  early  stages. 
 
Combination  therapies  use  more  than  one  drug  simultaneously  to  reduce  the  probability  of 
acquiring  resistance,  permit  the  use  of  lower  levels  of  each  individual  drug,  and  improve 
treatment  specificity 73–75 .  They  are  now  used  in  many  contexts,  however,  identifying  synergizing 
compounds  is  challenging,  and  mechanistic  explanations  are  difficult  to  establish 76 .  A  molecular 
level  understanding  of  drug  tolerance  in C.  albicans  will  open  a  door  to  a  long  corridor  that  ends 
in  a  new  type  of  therapeutic  that  targets  the  tolerance  phase.  By  careful  examination  of  the 
trajectories  across  different  conditions,  drugs  and  concentrations,  we  can  identify  the  most  likely 
“cut-points''  along  these  paths,  that  when  targeted,  would  eliminate  the  grace  period  for  an 





Materials  and  Methods 
 
1.  Nanolitre  droplet-based  single  cell  RNA-sequencing  (DROP-seq)  for  Fungi  
Yeast  ( S.  cerevisiae )  has  previously  been  examined  by  single  cell  sequencing  using  the 
Fluidigm  C1  system  but  this  handles  less  than  100  cells 57 .  Jackson  et  al 77 sequenced  ~40K S. 
cerevisiae  cells  with  the  commercial  Chromium  (10X  Inc.)  system.  We  opted  to  build  a  fungal 
DROP-seq  modified  from  the  original  approach  presented  in  Macosko  et  al 52,53 ,  to  address 
issues  of  cost  and  flexibility  in  comparison  with  commercial  alternatives. In  general,  DROP-seq 
devices  have  been  shown  to  be  near  equivalent  to  commercial  systems 78 .  In  particular,  here  we 
built  a  printed  circuit  board  to  control  microfluidic  flow  inspired  by  Stephenson  et  al 79 ,  and  3D 
printed  plastic  syringe  pumps  and  cheap  cameras  inspired  by  Booeshaghi  et  al 80  .  The  cost  per  
device  is  well  below  $1K  CDN.  
 
2.  Strains  and  media  
C.  albicans SC5314,  cells  were  grown  in  YPD  liquid  media  (2%  D-glucose,  2%  peptone,  1% 
yeast  extract,  0.01%  uridine)  and  incubated  at  30°C  for  12-16  hours.  Afterwards  an  aliquot  of 
10 8  cells  (representing  10ml  of  culture  with  OD  1  in  600nm)  was  taken  and  used  as  the  
untreated  sample.  We  then  pelleted  the  cells  with  centrifugation,  discarded  the  supernatant  and 
introduced  1ml  RNAlater  (Sigma  #  R0901)  and  froze  the  resultant  colony  at  -20°C  for  later  use 
in  the  DROP-seq.  Other  aliquots  were  used  for  drugs  treatment  experiments.  In  order  to  have 
enough  log-phase  cells  for  our  multiple  drugs  in  different  timepoints,  we  used  the  following 
protocol.  Cells  were  pelleted  and  resuspended  in  1ml  of  YPD.  Then,  250 μ l  of  this  suspension 
was  combined  with  15ml  of  fresh  YPD  and  placed  in  a  shaker  incubator  at  30  °C  for  4-5  hours. 
Finally,  on  the  order  of  10 8 of  these  cells  were  placed  in  10ml  of  YPD.  Each  suspension  was  then 
subjected  to  drug  treatment.  
 
3.  Anti-fungal  drug  treatment  
A  concentration  of  0.01  mg/ml  was  chosen  for  both  fluconazole  (Sigma  #F8929)  and  nystatin 
(Sigma  #N6261),  representing  a  moderate  dosage  relative  to  their  reported  MIC50 
levels 10,46–48,81 .  A  concentration  of  1ng/ml  was  used  for  caspofungin  (Sigma  #SML0425),  a 
compound  that  interrupts  cell  way  biosynthesis 50,51,82 ;  this  is  well  below  its  reported  MIC50  levels 
and  chosen  in  order  to  ensure  a  sufficient  number  of  survivors  to  generate  single  cell  profiles. 
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The  target  drug  was  delivered  to  the  individual  colonies  from  step  2  and  incubated  at  30  °C  for 
48  or  72  hours.  Cells  at  these  time  points  were  strained  (pluriStrainer®  20  µm)  and  collected  in 
fresh  tubes.  This  was  done  in  order  to  minimize  the  likelihood  that  the  microfluidic  chip  would 
block  due  to  large  hyphae  and  pseudohyphae  morphologies.  We  observed  that  germ  tubes  up  to 
four  times  the  length  of  the  mother  cell  can  still  be  processed  for  drop-seq  analysis 
( Supplemental  Figures  3,  4  and  additional  quantitative  analysis  in  progress).  Such  cells  are 
well  within  the  hyphal  transcriptional  profile.  This  suggests  that  our  profiles  do  contain  hyphae 
and  pseudohyphae  cells.  
 
4.  Spheroplasts  
The C.  albicans  setting  required  an  optimized  protocol  for  cell  preparation  with  specific 
techniques  to  remove  the  cell  wall  and  induce  stable  spheroplasts.  Towards  this  end,  we 
experimented  with  different  concentrations  of  zymolyase  (0.1,  0.2  and  0.4U  zymolyase  (BioShop 
#  ZYM002)  with  10 7 cells  in  100  ul  of  sorbitol  1M  at  different  time  points  (stored  at  37  °C  for  10, 
20,  30  mins)  before  processing  with  the  DROP-seq.  To  compare  against  untreated  populations 
cells  were  stained  with  calcofluor  white and  imaged  with  microscopy  (Leica  DM6000) .  We 
concluded  that  concentrations  in  the  range  0.1-0.2U  after  20  minutes  are  able  to  induce 
spheroplasts  that  remain  sufficiently  stable  for  processing  with  our  DROP-seq .  These  represent 
concentrations  similar  to  the  protocol  for  10x  from   Jackson  et  al.  
 
5.  Cell  preparation  
Drug  treated  colonies  at  either  the  48  or  72  hours  were  pelleted  by  brief  centrifugation  and 
washed  two  times  with  1ml  RNAlater.  Cells  were  then  resuspended  in  0.5ml  of  RNAlater  and 
stored  at  room  temperature  for  one  hour,  following  the  company’s  protocol.  Afterwards,  they 
were  put  in  -20  °C  for  at  least  24  hours  before  passing  through  the  DROP-seq.  At  the  time  of  cell 
preparation  for  the  DROP-seq  protocol,  an  aliquot  of  10 7 (OD=0.68  in  660  nm)  cells  from  each 
colony  was  taken,  and  each  colony  was  washed  three  times  with  sorbitol  1M.  The  cells  were 
then  resuspended  in  100 μ l  sorbitol  1M  +  0.2  U  Zymolyase  and  incubated  at  37  °C  for  20 
minutes  (as  per  our  findings  in Methods  3 ).  The  use  of  RNAlater  before  this  step  minimizes  the 
chance  of  any  transcripts  changes  during  Zymolyase  treatment.  Next,  the  cells  were  pelleted 
and  resuspended  again  in  0.5ml  of  cold  and  fresh  RNAlater  for  five  minutes.  The  cells  were  then 
washed  (centrifuged  and  pelleted)  with  1ml  of  washing  buffer  (1M  sorbitol,  10mM  TRIS  pH  8, 
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100ug/ml  BSA)  three  times.  Finally,  10 6  cells  (OD=0.08  in  660nm)  were  resuspended  in  1.2  ml  of  
the  washing  buffer.  This  cell  suspension  was  then  used  as  input  to  the  DROP-seq  device.  
 
6.  Fungal  DROP-seq  protocol  
Cell  preparation  generally  follows  the  protocol  given  by  Macosko  et  al 52,53  with  some  exceptions.  
Whereas  Macosko  et  al  recommends  a  ratio  of  100K  cells  to  120K  beads  for  DROP-seq,  we 
found  that  a  ratio  of  1M  cells,  for  120K  beads  generated  a  sufficient  yield  of  cDNA  as  per  the 
Agilent  Tapestation.  We  hypothesise  this  is  perhaps  due  to  the  fa ct  that  Candida  cells  are  much 
smaller  than  mammalian  cells,  and  therefore  more  cells  tend  to  not  be  captured  in  droplets. 
Jackson  et  al 77 used  5M  cells  as  input  to  the  Chromium  (10X  Inc.)  system.  Furthermore,  
whereas  Macosko  et  al.  use  1ml  of  lysis  buffer,  we  used  1.2  ml,  and  instead  of  13  PCR  cycles, 
we  used  17  ( Jackson  et  al.  used  10  cycles). Samples  were  sequenced  using  the  Illumina 
NextSeq500  following  a  standard  protocol 52   (200M  reads/sample). 
 
7.  Bioinformatics  and  statistics  for  the  single  cell  profiles  
In  general,  all  computations  were  performed  using  Python  version  3.67  or  R  version  3.6.1.  Gene 
abundances  were  estimated  from  raw  sequencing  data  using  the  end-to-end  pipeline  Alevin 83  
which  optimizes  UMI  deduplication  and  reduces  the  number  of  discarded  (multi-mapped)  reads. 
SCANPY 84 ,  a  python-based  toolkit  for  analyzing  single-cell  gene  expression  data  was  used  for 
data  quality  control  and  preprocessing.  We  selected  cells  with  at  least  30  genes  and  50  read 
counts  under  the  condition  that  less  than  half  were  found  in  ribosomal  genes  (RDN).  We 
removed  genes  that  were  observed  to  be  expressed  in  less  than  20  cells.  Normalization, 
imputation  and  batch  correction  were  performed  by  scVI 85,86 ,  a  tool  which  implements  a 
probabilistic  model  of  mRNA  capture  and  uses  a  variational  autoencoder  to  estimate  priors 
across  batches  and  conditions  ( Supplemental  Figure  1 ).  
8.  Approaches  for  identifying  subpopulations  with  distinct  states  and  expression  patterns 
To  identify  subpopulations  of  cells  with  similar  gene  expression  patterns  in  an  unsupervised 
manner,  dimensionality  reduction  and  visualization  was  based  on  UMAP 87  with  Louvain 88   
clustering.  
UMAP.  Traditional  gene  clustering  used  Pearson  correlation  distance  (or  a  similar  metric  such  as 
Euclidean  distance)  to  identify  and  group  genes  or  samples  that  had  similar  behavior.  Single  cell 
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analysis  does  not  do  well  with  such  traditional  approaches  for  a  number  of  reasons.  Perhaps 
the  main  limitation  is  that  many  genes  have  “zero  counts”  in  many  cells.  Zero  counts  can  occur 
because  the  transcript  is  truly  not  in  the  cell  (we  term  this  a  biological  zero)  or  because  the 
technology  misses  it  (a  technical  false  negative).  The  single  cell  community  turned  to  more 
complicated  non-linear  manifold  embeddings  and  sophisticated  machine  learning  techniques  to 
help  with  this  problem.  You  can  think  of  a  manifold  as  a  sort  of  continuous  cloud  in  three 
dimensions  (although  the  data  is  much  higher  dimensional).  The  cells  are  mapped  to  this 
non-linear  surface.  The  fact  that  it  is  non-linear  (as  compared  to  linear  embeddings  typical  of 
classic  clustering)  gives  many  more  degrees  of  freedom  to  retain  “neighbourhood  properties”. 
That  is,  we  can  map  our  cells  onto  the  surface  of  this  curvy  shape  in  high  dimensional  space  so 
that  two  cells  that  have  similar  transcriptional  profiles  are  almost  always  close  to  each  other, 
across  our  panels  with  1000s  of  cells.  Then  UMAP  takes  the  shape  of  a  high-dimensional 
surface  and  projects  the  cells  and  their  expression  profile  onto  a  two-dimensional  plane  (what 
you  see  in  Figures  2-6).  Again  the  algorithm  tries  to  conserve  nearest  neighbor  relationships: 
points  near  each  other  on  the  multidimensional  manifold  are  also  close  to  each  other  on  the 
two-dimensional  plane.  That  is,  similar  cells  co-cluster. 
 
Louvain  is  a  so-called community  detection  algorithm.  The  principle  is  that  it  builds  a  graph 
where  nodes  are  cells  and  two  cells  are  connected  if  they  have  similar  transcriptional  profiles. 
Conceptually  each  cell  builds  a  community  consisting  of  its  k  nearest  neighbors  graph  as 
defined  by  their  similarity  in  gene  expression  profiles.  Finally,  the  algorithm  considers  what 
every  cell  believes  is  its  neighbourhood  and  forms  a  consensus  of  clusters  across  the  data. 
 
9.  Gene  signatures  
Supplemental  Table  2  lists  all  of  the  gene  signatures  used  throughout  the  analysis.  In  some 
cases,  gene  signatures  from  the  literature  arise  from  studies  in  other  organisms  and  therefore 
required  orthology  mappings  to C.  albicans .  For  example,  the S.  cerevisiae  derived 
Environmental  Stress  Response  (ESR) 56  contains  859  genes  and  is  divided  into  three  broad  
categories  called  the  induced  ESR  (iESR;  genes  that  are  differentially  regulated  in  response  to 
environmental  xenobiotics,  conditions  or  other  challenges),  the  ribosomal  proteins  (RP)  and  the 
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ribosomal  biogenesis  genes  (RiBi;  involved  in  rRNA  production,  growth  and  cell  division).  To 
generate  a C.  albicans  version  of  the  ESR,  we  downloaded C.  albicans  (strain  SC5314) 
assembly  21  and  Sc  (S288C)  orthology  maps  from  the  Candida  Genome  Database 
( http://www.candidagenome.org/ ),  and  synteny  maps  from  the  Candida  Gene  Order  Browser 89  at  
this  website.  For  each S. cerevisiae  gene  we  almost  always  used  synteny  as  the  primary 
attribute  determining  the  correct C.  albicans  orthologue.  When  these  databases  failed  to  identify 
a C.  albicans gene,  we  manually  evaluated  the  quality  of  the  reciprocal  best  BLAST-p rotein 
alignment  between S.  cerevisiae  and C.  albicans .  In  total,  orthologs  for  642  of  the  859 S. 
cerevisiae  ESR  genes  were  identified  ( Supplemental  Table  5 ). 
The  list  of  gene  signatures  consists  of  the  following:  ras  pathway 36  ,  ergosterol  biosynthesis 12,90   
,hyphae  morphology 91  ,  calcineurin  pathway 92,93  ,  oxidative  stress 94 ,  cell  wall  biosynthesis 49,95  ,    
efflux  pumps 10,11 ,  pseudohyphal  morphology 96  ,  heat  shock 97  ,  biofilm 38  ,  opaque  morphology 98  ,     
iron  starvation 56,82  ,  parasexual  and  meiosis 28,99  ,  germ  tubes 98  ,  white  morphology  and  early    
filamentous  morphology 100  .  The  genes  for  each  signature  are  listed  in Supplemental  Table  2  
and  5 . 
 
10.  Approaches  for  exploring  the  molecular  components  of  subpopulations  
Our  univariate  analyses  started  with  a  simple  Welch t -test  to  identify  genes  that  are  strongly 
differentially  expressed  between  two  given  target  populations.  Five  of  6  markers  were  significant 
at  a  pvalue  of  0.01,  however  we  did  not  make  adjustments  for  multiple  testing  nor  false 
discovery.  Rather  we  focused  on  a  choice  of  genes  that  had  the  most  evidence  of  differential 
expression  between  the  subpopulations  to  serve  as  good  biomarkers  in  the  downstream 
microscopy  validation  studies.  When  selecting  for  marker  genes,  we  narrowed  our  focus  towards 
genes  that  were  strongly  up-regulated  in  one  cluster.  Our  multivariate  analyses  started  with  the 
VISION  tool 101  to  identify  sets  of  genes  that  are  strongly  differential  between  two  given  target  
populations.  Given  a  gene  signature  ( Methods  9 ),  VISION  computes  a  signature  score  based 
on  a  combination  of  gene  expression  and  a  precomputed  cell-cell  similarity  map.  A 
representative  score  for  each  signature  is  computed  for  every  cell,  which  is  calculated  as  the 
sum  of  expression  values  of  positive  genes  minus  the  sum  of  expression  of  negative  genes. 
The  sign  of  a  gene  is  determined  as  follows:  genes  which  are  known  to  be  up-regulated  in  a 
biological  process  are  given  a  positive  sign,  while  genes  that  are  known  to  be  down-regulated  in 
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a  biological  process  are  given  a  negative  sign.  In  cases  where  sign  information  is  not  known, 
every  gene  is  given  a  positive  value.  Each  signature  score  is  divided  by  the  total  number  of 
genes  in  the  signature.  Additionally,  each  signature  is  z-normalized  using  the  expected  mean 
and  variance  of  a  random  signature  with  the  same  number  of  positive/negative  genes. 
 
11.  Live  cell  imaging  
Our  goal  is  to  use  live  cell  imaging  to  validate  subpopulations  identified  with  the  single  cell 
transcriptional  profiles.  We  proceeded  as  follows. 
 
11a.  Genes  were  selected  whose  expression  profiles  were  differential  expressed  between 
subpopulations  at  each  time  point  as  described  in Methods  5 .  This  list  of  genes  was  winnowed 
down  to  one  gene  in  each  subpopulation  with  high  expression  levels.  We  limited  validation 
studies  to  the  two  most  distinct  subpopulations  at  each  time  point  (UT,  FCZ  48h,  FCZ  72h).  In 
this  manner,  we  required  three  pairs  of  marker  genes,  one  tagged  with  GFP  and  one  with  RFP.  
 
11b.  Primers  were  designed  for  these  six  target  genes  ( Supplemental  Table  1 ).  Strain 
SN76( his1Δ/his1Δ,  arg4Δ/arg4Δ,  ura3Δ/ura3Δ )  was  chosen  for  gene  tagging,  since  it  is  a 
derivative  strain  of  SC5314  but  with  multiple  auxotrophic  markers.  These  markers  allow  for 
convenient  selection  of  cells  which  have  successfully  integrated  the  fluorescent  protein  in 
addition  to  the  auxotroph  marker  (eg HIS1 )  via  homologous  recombination  at  the  3’  position  of 
the  target  genes  ( Supplemental  Figure  5B ).  
 
11c.  Benchling  ( https://benchling.com )  was  used  to  design  the  sgRNAs  and  we  followed  the 
CRISPR/Cas9  protocol  with  the  plasmid  pV1093  from  Min  et  al 102 .  This  includes  two  PCR 
reactions  to  fuse  the  SNR52  promoter  to  the  sgRNA  scaffold  and  terminator.  The  third  PCR 
reaction  amplifies  the  final  sgRNA  cassettes.  Two  different  plasmids  pENO1-iRFP-NATr 
(Addgene  Inc)  and  pFA-GFP-HIS1  were  used  to  design  the  repair  segment.  The  construction  of 
the  Cas9  cassette  proceeded  as  per  Min  et  al. Amplification  of  the  Cas9  cassette  with  PCR  used 
the  following  schedule:  98°C  for  3  minutes,  98°C  for  30  seconds,  63°C  for  30  seconds,  72°C  for 
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5  minutes  and  30  seconds.  Steps  2  to  4  have  been  repeated  for  34  rounds  followed  by  72°C  for 
10  minutes  and  finally  the  reaction  finished  in  4°C.  The  repair  DNA  must  be  amplified  with  the 
designed  primers  described  in Supplemental  Table  1  in  8-12  PCR  tubes  with  0.1 μ l  plasmid 
(500ng/ml),  2.5 μ l  forward  primer,  2.5 μ l  reverse  primer,  1 μ l  10mM  dNTP,  33.65 μ l  nuclease  free 
water,  10 μ l  5X  HF  PCR  buffer  and  0.25 μ l  phusion  polymerase  in  each  tube.  
 
11d.  Preparation  of  cell  colonies  for  microscopy.  Cells  that  were  successfully  transformed  were 
grown  and  harvested  for  each  drug  at  each  timepoint  in  a  manner  identical  to  that  used  for  the 
single  cell  experiments  ( Methods  4 ).  At  time  of  microscopy,  10^6  cells  were  collected,  washed 
with  H2O  and  transferred  to  minimum  media  to  minimize  the  background  noise  from  normal 
YPD  media.  After,  cells  were  mounted  onto  the  uSlide  and  imaged  with  Nikon  Ti  microscope  and 
Photometric  camera  each  five  minutes  for  three  hours. 
 
12.  Bulk  DNA-sequencing  
12a.  DNA  was  extracted  from  UT  and  drug  treated  cells  after  48hrs,  72hrs,  6  days  and  12  days 
( Methods  3 ).  Since  the  media  was  saturated  with  cells  at  72  hours,  we  sampled  10 8  cells  from  
the  population  and  added  10ml  of  new  media  with  a  second  pulse  of  the  drug  to  the  culture. 
Cells  were  harvested  for  sequencing  at  6  days.  This  procedure  was  repeated  at  the  9  day  time 
point  for  cells  to  be  harvested  at  day  12.  Before  harvesting,  cells  were  maintained  at  30°C  in  an 
incubator  with  rotation.  
 
12b.  When  isolating  genomic  DNA  (gDNA),  1.5ml  of  saturated  media  (approximately  8-10  A600 
units  for  each  ml)  were  pelleted  as  specified  by  the  MasterPure  Yeast  DNA  Purification  Kit 
Protocol  (Epicentre  #MPY80200).  Concentration  and  fragment  length  of  the  gDNA  was 
measured  using  a  4150  Tapestation  (Agilent)  on  a  Genomic  DNA  ScreenTape  (Agilent 
#5067-5365 ) ( Supplemental  Figures  6-9 ).  The  Nextera  XT  (Illumina  #FC-131-1024)  kit  was 
used  for  tagmentation  following  the  protocol  from  the  manufacturer.  All  13  samples  were  then 
multiplexed  using  the  Nextera  XT  Indexing  Primers  and  sent  for  sequencing  utilizing  the 
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NextSeq  500  platform.  A  mid-throughput  chip  with  2  x  80bp  paired-end  reads  (Ilumina 
# 20024904 )  is  expected  to  generate  a  total  of  20.8  billion  nucleotides. 
  
We  rationalized  that  a  average  sequencing  depth  of  100x  would  provide  sufficient  power  to 
detect  (1)  SNPs,  (2)  ploidy  (haploid  versus  diploid  versus  tetraploid),  (3)  gains  (from  aneuploidy) 
and  (4)  losses  (from  aneuploidy),  under  several  assumptions  including  that  Response  A  has  a 
set  of  defining  genomic  events  that  are  common  to  almost  all  Response  A  cells  and  similarly 
Response  B  has  a  set  of  defining  genomic  events  that  almost  all  Response  B  cells  have.  Our 
depth  of  100x  is  sufficient  to  identify  events  with  a  p-value  <  0.05  under  a  broad  range  of 
different  scenarios  (eg  a  defining  SNP  of  Response  A  occurs  in  a  tetraploid  genome,  a  loss  of 
heterozygosity  event  occurs  in  a  haploid  genome).  We  stress  that  our  independent  power 
analysis  (not  shown)  arrived  at  the  same  sequencing  depth  requirement  as  others  in  this 
domain 17,18 .  
 
The  SC5314  genome  is  approximately  14.28  Mbp  and  therefore  requires  1.428  billion  base  pairs 
for  each  sequencing  run  per  sample  to  generate  an  expected  100x  coverage.  As  we  have  13 
multiplexed  samples  in  total,  this  requires  13  *  1.428  =  18.546  billion  nucleotides,  a  number  less 
than  the  expected  20.8  billion  nucleotides  generated  by  a  full  run  of  the  NextSeq  500. 
 
12.c  Bioinformatics  analysis  will  follow  Ford  et  al. 17 ,  a  previous  effort  from  the  Broad  Institute  that 
sequenced  whole  genome  DNA  of  clinical C.  albicans  samples.  All  reads  will  be  mapped  to  the 
SC5314  reference  genome  ( Methods  9 )  using  the  BWA  alignment  tool  (version  0.7.1.7).  Single 
nucleotide  polymorphisms  (SNPs  will  be  identified  using  HaplotypeCaller  (GATK  version  4.1.4.1) 
and  unreliable  SNPs  will  be  identified  using  the  GATK  Variant  Filtration  module,  with  the  version 
4  best  practices  annotation  filters  (QD  <  2.0),  MQ  <  40.0,  FS  >  60.0,  HaplotypeScore  >  13.0, 
MQRankSum  <  -12.5,  ReadPosRankSum  <  -8.0).  A  SNP  matrix  of  all  samples  by  position  will 
be  computed  where  an  entry  is  1  if  a  sample  has  a  SNP  at  that  position  and  0  otherwise.  We  will 
also  exploit  the  approaches  in  Ford  et  al.  for  determining  copy  number  variation  and  loss  of 
heterozygosity  (LOH). 
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Figure  1 A.  The  potential  trajectories  of  a  fungal  population  challenged  with  an  antifungal  agent 
at  time  t 0 .The  pre-existence  or  the  quick  evolution  in  the  founder  population  of  a  latent 
advantageous  mutation  ( * and  subsequent  blue  fraction)  before  drug  exposure  confers  survival 
(population  A).  The  remaining  populations  B-E  lack  such  a  preexisting  mutation.  Cells  that  do 
not  mount  a  sufficient  epigenetic  tolerance  defense  die  off  (B).  This  proposal  is  focused  on 
populations  C,D,E  that  are  each  able  to  enlist  an  appropriate  tolerance  response.  In  some 
subpopulations  (E),  genetic  events  ultimately  occur  that  confer  long-term  resistance  ( **,  yellow ), 
33 
whereas  other  subpopulations  (C)  may  die  off.  Some  subpopulations  (D)  may  survive  the  drug 
through  epigenetic  modulation  alone. B. Survey  of  results  from  fungal  DROP-seq  across 
different  populations. C. Histogram  describing  the  number  of  cells  with  observed  levels  of 
transcripts. D.  Violin  plots  describing  the  distribution  of  transcript  numbers. E.  Histogram 






Figure  2  A. UMAP  based  visualization  of  the  relationship  between  all C.  albicans  populations 
labelled  by  population  of  origin. Color  codes  for  the  cells  are  shown  in  the  bottom  left  of  the 
UMAP.  For  example,  brown  dots/cells  are  untreated  (UT). B.  UMAP  embedding  from  A  but  here 
color  reflects  unsupervised  Louvain  found  that  many  have  well  established  roles  in  different 
stress  responses  including HSP21,  HGT6  and CAS5  (core  stress  response), GAC1,  XYL2  and 
ADH2  in  acid  stress, SOD3,  YCF1  and OXR1 in  clustering  using  VISION. C. Pattern  of  
expression  of  the  efflux  pump  gene  signature  mapped  onto  the  UMAP  embedding  of  A. D. 
Pattern  of  expression  of  white  and  hyphae  gene  signatures. E,  F. Pattern  of  expression  for  the 
iESR  and  Ribosomal  Protein  (RP)  signatures. G. Summary  of  expression  of  our  collection  of  all 






Figure  3  A. Visual  representation  (UMAP)  of  the  relationships  of  only  untreated  (UT)  cells.  In 
total,  15  subpopulations  are  highlighted  via  Louvain  clustering. B.  Pattern  of  expression  of  the  
iESR  and  Ribosomal  Protein  (RP)  signatures  mapped  onto  the  UMAP  embedding  of  A.  C.  Gene 
expression  of  the  endoplasmic  reticulum  chaperone HSP70  (top),  the  ABC  transporter PRN3 
(middle)  and  dithiol  glutaredoxin TTR1  (bottom)  across  UT  cells. D.  Gene  expression  of  the 
endoplasmic  reticulum  chaperone HSP70  (top),  the  ABC  transporter PRN3  (middle)  and  dithiol 
glutaredoxin TTR1  (bottom)  across  all  cells  (drugs/timepoints)  but  with  UT  cells  highlighted  in 
the  UMAP  embedding  of  all  cells. E.  Summary  of  expression  of  all  signatures  across  the 







Figure  4 A. Visual  representation  (UMAP)  of  the  relationships  of  only  FCZ-48  cells.  In  total,  9 
subpopulations  are  highlighted  via  Louvain  clustering. B. Expression  of  the  iESR  across  all 
cells  (drugs/timepoints)  but  with  FCZ-48  cells  highlighted. C. Expression  of  the  Membrane,  
Oxidative  and  Ergosterol  signatures  mapped  onto  the  UMAP  embedding  of  A. D.  Gene 
expression  of  the UCF1  (top)  and CMD1  (bottom)  across  FCZ-48  cells E.  Summary  of  all 






Figure  5 A. Visual  representation  (UMAP)  of  the  relationships  of  just  FCZ-72  cells.  In  total,  10 
subpopulations  are  highlighted  via  Louvain  clustering. B. Summary  of  all  signatures  across  the 
Louvain  clusters  identified  across  all  FCZ-72  cells. C. Expression  of  the  Biofilm  signature  onto 
the  UMAP  embedding  of  A  (left)  and  onto  the  UMAP  embedding  of  all  cells  (drugs/timepoints) 
but  with  FCZ-72  cells  highlighted  (right). D.  UMAP  based  visualization  of  the  relationship 
between  UT,  FCZ-48  and  FCZ-72  cells  labelled  by  cell  of  origin  (left),  expression  of  the  Efflux 




Figure  6  A. Gene  expression  of WH11  across  all  cells  (drugs/timepoints)  but  with  UT  cells 
highlighted  (left),  FCZ-48  cells  (middle),  and  FCZ-72-cells  (left)  highlighted. B. Gene 
expression  of YHB1  across  all  cells  (drugs/timepoints)  but  with  UT  cells  highlighted  (left), 




Figure  7  A. Visual  representation  (UMAP)  of  the  relationships  of  just  NYS-72  cells.  In  total,  9 
subpopulations  are  highlighted  via  Louvain  clustering. B-F . Expression  of  the  Heat  Shock 
Protein,  Oxidative,  White,  Iron  and  Membrane  signatures  mapped  onto  the  UMAP  embedding  of 









Supplemental  Figure  1  Patterns  of  expression  of  cell  cycle  signatures  mapped  onto  the  UMAP 
embedding  of  all  cells  (left),  mapped  onto  the  UMAP  of  UT  cells  (middle),  and  mapped  onto  the 





Supplemental  Figure  2  A. Histograms  describing  the  number  of  cells  with  observed  levels  of 
transcripts  (top)  and  genes  (bottom)  before  normalization  and  imputation. B. Histograms 
describing  the  number  of  cells  with  observed  levels  of  transcripts  (top)  and  genes  (bottom)  after 
normalization  and  imputation. C. Violin  plots  describing  the  distribution  of  transcript  number 
(top),  fraction  of  transcripts  of  genes  with  an  RP  prefix  (middle),  and  fraction  of  transcripts  of 
genes  with  an  RDN  prefix  (bottom)  before  normalization  and  imputation. D. Violin  plots 
describing  the  distribution  of  transcript  number  (top),  fraction  of  transcripts  of  genes  with  an  RP 
prefix  (middle),  and  fraction  of  transcripts  of  genes  with  an  RDN  prefix  (bottom)  after 
normalization  and  imputation. 
 
 
Supplemental  Figure  3  A. Images  taken  under  the  microscope  of  CSP-48  cells  without  (left) 
and  with  a  cell  strainer  (right).  B. Images  taken  under  the  microscope  of  FCZ-48  cells  without 
47 
(left)  and  with  a  cell  strainer  (right).  The  circle  highlights  the  germ  tube  and  small  hyphae  cells 
after  applying  the  strainer.  Scale  bars  represent  20  micron. 
 
 
Supplemental  Figure  4  A. Images  taken  under  the  microscope  of  NYS-48  cells  without  (left) 
and  with  a  cell  strainer  (right).  B. Images  taken  under  the  microscope  of  FCZ-72  cells  without 









Supplemental  Figure  5 . A. Gel  electrophoresis  results  for  genes  successfully  tagged  with RFP . 
The  ~3Kb  bands  (bands  in  the  red  boxes)  confirm  that  these  genes  are  successfully  tagged  with 
RFP  in  those  colonies.  The  size  of RFP  is  almost  2400bp.  The  lowest  row  corresponds  to 
primers.  Bands  in  the  middle  row  are  genes  not  tagged  with RFP .  Therefore  the  bands  indicate 
the  actual  size  of  these  genes. B. Schematic  figure  showing  the  green  fluorescent  protein  (GFP) 
tagging  at  the  3’  position  of  the  target  gene  to  form  the  fusion  protein.  GFP  is  used  for  genes 
YHB1,  UCF1,  and  HSP70.  The  same  procedure  was  used  for  RFP  tagging  for  WH11,  CMD1 
and  TTR1.  P  indicates  the  promoter  of  the  target  gene.  S.M  stands  for  selective  marker  ( HIS1 
in GFP  case).  Red  arrows  show  the  position  of  designed  primers.  When  successful  gene 
insertion  of  the  PCR  products  occurs,  the  designed  primers  will  result  in  big  bands  with 









Supplemental  figure  6. Concentration  versus  fragment  length  for  the  extracted  genomic  DNA 
via  the  Tapestation  (Agilent  Inc.).  The  top  and  bottom  panels  correspond  to  CSP  and  NYS  at  12 
days.  The  average  size  of  purified  DNA  molecules  is  40-50  kb,  which  is  in  the  ideal  range 
according  to  the  manufacturer’s  protocol  ( MasterPure  Yeast  DNA  purification  kit, Methods  12 ). 
Overall  concentration  is  more  than  sufficient  for  bulk  whole  genome  DNA-seq  via  the  Illumina 








Supplemental  Figure  7 .  Tapestation  results  for  gDNA  of  FCZ-treated  cells.  Analogous  to 






Supplemental  Figure  8 .  Tapestation  results  for  gDNA  of  NYS-treated  cells.  Analogous  to 






Supplemental  figure  9 .  Tapestation  results  for  gDNA  of  CSP-treated  cells.  Analogous  to 










Supplemental  Figure  10. Our  fungal  DROP-seq  system.  The  small  screen  is  driven  by  a 
Raspberry  Pi  CPU  and  controls  the  pumps:  two  on  the  left  for  oil  and  cells  and  one  on  the  right 













 Name Sequence 
1 TTR1-P3  oligo ATTTAAACAATGTCGAACGTgttttagagctagaaatagcaagttaaa 
2 TTR1-P2  oligo ACGTTCGACATTGTTTAAATcaaattaaaaatagtttacgcaagtc 
3 TTR1-RFP-For GTCAACATATTGGTGGCAATTCCGATGTGCAAGCTTTGAAGTCTAGTGACAA 
ATTAGATGACAAAATCAAAGCTGCTTTAatggttatggctagaaaagtt 
4 TTR1-NAT-Rev AATTCCATTTCTTGGGGAATGTCCACTTGTTGTGCCAAAACACTGTCTTCTG 
TGGAATTAGAAACATGCTGAATATACCCcagcagtatagcgaccagcat 
5 TTR1-Check-For TGTTCCGTACATTATTAAC 
6 TTR1-Check-Rev ATATCTCTTTTGGTATTGTTT 
7 HSP70-P3  oligo AAGAAATAGGTAATTTACTGgttttagagctagaaatagcaagttaaa 
8 HSP70-P2  oligo CAGTAAATTACCTATTTCTTcaaattaaaaatagtttacgcaagtc 
9 HSP70-GFP-For CAGGTGGTGCCCCAGGTGCCGGTGGTCCAGGTGGTGCTACTGGTGGTGAATC 
AAGTGGACCAACTGTTGAAGAAGTTGATggtgctggcgcaggtgcttc 
10 HSP70-HIS1-Rev CCCATAAATAAAAAATTGTTCTAAATATTGTGCTTCTTTCTTTTTTGTTGAT 
CTTTACTTACTTACTTACAAAAGCAAAGccgcataggccactagtgga 
11 HSP70-Check-For TATGTCTAAAGCTGTTGGTATTGAT 
12 HSP70-Check-Rev TGTTTATCATTGTTTGCAACTTTAT 
13 CMD1-P3  oligo GTTGACATTCGTCTCTTCTGgttttagagctagaaatagcaagttaaa 
14 CMD1-P2  oligo CAGAAGAGACGAATGTCAACaaattaaaaatagtttacgcaagtc 
15 CMD1-RFP-For ATCAAATGATTAAAGAAGCTGATACCAACAATGATGGTGAGATTGATATCCA 
AGAATTTACTCTGTTATTAGCAGCTAAAatggttatggctagaaaagtt 
16 CMD1-NAT-Rev CCAGTATTGCCAGCTTTACAATGTAGAAAAGGAAAAAGTAGAGTAATGCTAC 
TAATGACAAATAATCAAATAATTAGTACcagcagtatagcgaccagcat 
17 CMD1-Check-For GTGACAGTTGTTCAAGATGA 
18 CMD1-Check-Rev TGACAGTGAATTGGAGAAAT 
19 UCF1-P3  oligo TATGTTGTTACTGTTGCTGTgttttagagctagaaatagcaagttaaa 
20 UCF1-P2  oligo ACAGCAACAGTAACAACATAcaaattaaaaatagtttacgcaagtc 
21 UCF1-GFP-For GACATTGGAGATTGGAATTGGATGTTTCTTGTACAAATGAATCAGCTATGGT 
TGATGTTGAATATAAATCCATTCCAATGggtgctggcgcaggtgcttc 
22 UCF1-HIS1-Rev TCATTAATTCGTAAAACGCATCATACATAAATATCATATTAAAATAAAAAAA 
ATAGAAGGAACAAACATAGCATCATAACccgcataggccactagtgga 
23 UCF1-Check-For TGGCGGGAAAGAAAAAGTCTAAGTC 
24 UCF1-Check-Rev CATCGTCGATAAACCTTAATTTCTCTA 
25 WH11-P3  oligo GTCAAATTTGTAGATTTGTGgttttagagctagaaatagcaagttaaa 
26 WH11-P2  oligo CACAAATCTACAAATTTGACcaaattaaaaatagtttacgcaagtc 
54 
27 WH11-RFP-For GTGCTGCTGGTAAAGCTACTTCTGAAAACGACAAATCATTTGTCCAAAAAGC 
TTCTGATGCTATTTTTGGTGACTCCAAAatggttatggctagaaaagttgat 
28 WH11-NAT-Rev ATTTTTGTTTTCCTTTGTTTTTTTAATTGATTTACGCGCATCAGTTATTAAG 
AACGGGAACGAAAGAAGTGAGACGCGACcagcagtatagcgaccagcat 
29 WH11-Check-For TGTCCGACTTAGGTAGAAAAG 
30 WH11-Check-Rev CCAGTTCTATCAGGACGATG 
31 YHB1-P3  oligo CTGACCAACTAAGCAGAAAGgttttagagctagaaatagcaagttaaa 
32 YHB1-P2  oligo CTTTCTGCTTAGTTGGTCAGcaaattaaaaatagtttacgcaagtc 
33 YHB1  -GFP-For AGTTTATGAAAGATATCAAAGAACATTTGGGTAAAAAGAATGTTCCTGTCAA 
GCTTGAATATTTTGGTCCTTACGATCCTggtgctggcgcaggtgcttc 
34 YHB1  -HIS1-Rev GAGAGTATTGTTTTAATAGTAATTACACAAAACTTTAACATTTTAGATTTAG 
GATTTACGAAGTCGCGTTTAATATTCCGccgcataggccactagtgga 
35 YHB1-Check-For GTCGAATACGAAACCAAACA 
36 YHB1-Check-rev TATGTAGGGAGGTTTGTGTT 
 
Supplemental  Table  1.  The  nucleic  acid  sequences  of  forward  (For)  and  reverse  (Rev)  primers 
used  for  the  target  genes  in  the  live  cell  imaging  experiments.  sgRNAs  (capital  letters)  are  fused 
to  P2  and  P3  oligos.  
 
 
Pathways/Stresses/Signatures Relevant  genes 
Ras  pathway 36 RAS1,  CYR1,  TPK2,  PDE2 
Ergosterol  biosynthesis 
pathway 12,90 
ERG2,  ERG13,  ERG27,  ERG6,  ERG1,  ERG8,  ERG25, 
ERG10,  ERG12,  ERG9,  ERG11,  IDI1,  UPC2 
Hyphae  signatures 91 RIM101,  IHD1,  SEC4,  SEP7,  RSR1,  DEF1,  CCH1, 
CDC12,  TUP1,  TEC1,  NRG1,  MID1,  NRG1.1,  DCK1, 
SEC2,  CDC11,  CDC42,  BRG1,  RAC1,  MOB2 
Calcineurin  pathway 92,93 HSP70,  HSP90,  CCH1,  MID1,  UTR2,  CNB1 
Oxidative  stress 94 TRX1,  CAT1,  TRR1,  SOD2,  CAP1,  MID1,  CCH1 
Cell  wall  biosynthesis 49,95 CHS2,  CHS3,  CHS8,  RLM1,  HOG1,  MKC1,  PBS2, 
MKK2 
Efflux  pumps  and 
transporter  proteins 10,11 
CDR1,  TAC1,  MDR1,  MRR1,  FLU1,  MLT1,  YOR1 
Pseudohyphal  signatures 96 TUP1,  NRG1,  FKH2,  TCC1,  RFG1,  SSN6,  ACE2, 
55 
RAP1,  CLB4,  GRR1 
Heat  shock  proteins 97 HSP12,  HSP70,  HSP21,  HSP60,  HSP90,  HSP104, 
HSP78 
Biofilm  formation 38 TYE7,  ROB1,  NDT80,  SOH1,  GCN4,  TEC1,  BRG1 
Opaque  cells  signatures 98 PGA31,  SOD1,  CCP1,  CYC1,  SDH2,  QCR9,  FESUR1, 
PCK1,  OSM2,  PEX4,  ACO1,  MET10,  RBT4,  CYB5, 
DAP1,  XOG1 
Iron  starvation  stress 56,82 HSP12,  STF2,  CCP1,  HMX1,  PHR2,  CAT1,  HAP2, 
HAP5,  HAP43,  MNN2 
Parasexual  and  meiosis 
genes 28,92 
SPO11,  SKI8,  CPH1,  CAG1,  DLH1,  NDT80,  HST6 
Germ  Tubes 98 HTA2,  HHF1,  HTA1,  HHT21,  ARX1,  ADE4,  HAS1 
White 98 PFY1,  RDI1,  SOD5,  YHB1,  PST1,  IHD1,  DPM1, 
SPC2,  ERV25,  ERV46,  RAS1,  PDI1,  CDC12,  KEX2, 
CDC10,  USO6,  PRE10,  CBP1,  PHR1 
Membrane 99 RBT5,  IHD1,  PHR1,  PGA7,  SAP10 
Early  Filamentous 100 SEC61,  IHD1,  HGT2,  ZDS1,  DCK1 
 
Supplemental  Table  2 Gene  sets  representing  pathways,  processes  and  morphological  states 




 Genes  
Log  FC  >  2 HSP21,  CTR1,  GAC1,  PGA48,  FGR41,  YHB1,  UCF1,  HSP70, 
TYE7,  SOD3,  SMC6,  NAD,  BLP1,  HGT6,  XYL2,  ADH2,  FAB1, 
PGK1,  YVC1,  IFE2,  YCF1,  OXR1,  GAC1,  ITS1,  CAS5,  APE3, 
REG1,  NDH51,  ARP9,  HHT21 
Log  FC  <  -2 RPL29,  RPL24A,  RPL43A,  RPL37B,  RPL30,  RPS21B,  NHP2, 
UBI3 
 
Supplemental  Table  3 Genes  which  are  showing  strong  differential  expression  between  cluster 






Log  FC  >  2.5 PGA57,  PXA1,  PRN3,  MRV3,  MRV8,  RLP24,  UBI4,  TYE7, 
INN1,  FMP45,  TOM70,  ELA1,  AOX2,  LOG3,  ERG25,  PGA31, 
SSY1,  JIP5 
Log  FC  <  -2 GIM5,  MET14,  RUB1,  DUT1,  ALT1,  X6,  RIM1,  GIR2,  SHE9, 
DBF4 
 
Supplemental  Table  4 Genes  which  are  showing  strong  differential  expression  in  cluster  1  and 





C  albicans 
Name CGD  ID 
S.  cerevisiae 
Name Sacc.  GID SGD  ID UID Signature  Group 
C4_04480C_A EFB1 CAL0000176377 EFB1 YAL003W S000000003 YAL003W RiBi 
C2_06360C_A MAK16 CAL0000176460 MAK16 YAL025C S000000023 YAL025C RiBi 
C1_08090C_A FUN12 CAL0000190309 FUN12 YAL035W S000000033 YAL035W RiBi 
C1_08100W_A DRG1 CAL0000193469 RBG1 YAL036C S000000034 YAL036C RiBi 
C2_05460W_A CDC19 CAL0000192883 CDC19 YAL038W S000000036 YAL038W RiBi 
C4_04100C_A ECM1 CAL0000196644 ECM1 YAL059W S000000055 YAL059W RiBi 
C1_04750W_A IFE1 CAL0000197952 BDH2 YAL061W S000000057 YAL061W iESR 
CR_04300W_A  CAL0000192993 NCL1 YBL024W S000000120 YBL024W RiBi 
C3_04510W_A  CAL0000196880 YBL028C YBL028C S000000124 YBL028C RiBi 
C1_07490C_A  CAL0000183205 POL12 YBL035C S000000131 YBL035C RiBi 
C5_04570C_A URA7 CAL0000193754 URA7 YBL039C S000000135 YBL039C RiBi 
C4_03430W_A MOH1 CAL0000187831 MOH1 YBL049W S000000145 YBL049W iESR 
C7_02810W_A PRX1 CAL0000196398 PRX1 YBL064C S000000160 YBL064C iESR 
C4_01820C_A  CAL0000186972 PRS4 YBL068W S000000164 YBL068W RiBi 
C1_05700W_A AUT7 CAL0000182486 ATG8 YBL078C S000000174 YBL078C iESR 
C6_01700W_A RPL32 CAL0000179592 RPL32 YBL092W S000000188 YBL092W RP 
C3_03470W_A  CAL0000178220 UGA2 YBR006W S000000210 YBR006W iESR 
C1_04890W_A YBN5 CAL0000180814 OLA1 YBR025C S000000229 YBR025C RiBi 
C3_00200C_A ETR1 CAL0000200874 ETR1 YBR026C S000000230 YBR026C iESR 
C1_14160W_A  CAL0000185918 RKM3 YBR030W S000000234 YBR030W RiBi 
C1_01030W_A HMT1 CAL0000187520 HMT1 YBR034C S000000238 YBR034C RiBi 
57 
C4_02760C_A CGR1 CAL0000196952 YBR053C YBR053C S000000257 YBR053C iESR 
C1_14060W_A  CAL0000194637 YBR056W YBR056W S000000260 YBR056W iESR 
C3_07400W_A  CAL0000176862 TRM7 YBR061C S000000265 YBR061C RiBi 
C1_12770W_A RPG1A CAL0000181001 RPG1 YBR079C S000000283 YBR079C RiBi 
C3_04500C_A RPL19A CAL0000180894 RPL19A YBR084C-A S000002156 YBR084C-A RP 
CR_07010W_A MIS11 CAL0000181460 MIS1 YBR084W S000000288 YBR084W RiBi 
CR_09320C_A PHO88 CAL0000189279 PHO88 YBR106W S000000310 YBR106W RiBi 
C1_08380W_A TEF2 CAL0000196876 TEF2 YBR118W S000000322 YBR118W RiBi 
C1_05290W_A GRS1 CAL0000176302 GRS1 YBR121C S000000325 YBR121C RiBi 
CR_05720W_A TPS1 CAL0000182821 TPS1 YBR126C S000000330 YBR126C iESR 
C1_05770C_A PRC3 CAL0000190176 YBR139W YBR139W S000000343 YBR139W iESR 
C2_05090W_A MAK5 CAL0000200900 MAK5 YBR142W S000000346 YBR142W RiBi 
C2_05100C_A ERF1 CAL0000184893 SUP45 YBR143C S000000347 YBR143C RiBi 
C2_08130W_A ARA1 CAL0000195767 ARA1 YBR149W S000000353 YBR149W iESR 
C1_12820C_A  CAL0000198535 RPB5 YBR154C S000000358 YBR154C RiBi 
C1_00560W_A CNS1 CAL0000195791 CNS1 YBR155W S000000359 YBR155W RiBi 
C2_03820C_A RPS9B CAL0000197665 RPS9B YBR189W S000000393 YBR189W RP 
C2_03810C_A RPL21A CAL0000194631 RPL21A YBR191W S000000395 YBR191W RP 
C1_04640W_A  CAL0000179190 LDH1 YBR204C S000000408 YBR204C iESR 
C3_06700C_A  CAL0000189293 YBR238C YBR238C S000000442 YBR238C RiBi 
C2_07920W_A  CAL0000182585 RRT2 YBR246W S000000450 YBR246W RiBi 
C7_03700C_A ENP1 CAL0000201090 ENP1 YBR247C S000000451 YBR247C RiBi 
C1_05110C_A ARO4 CAL0000182853 ARO4 YBR249C S000000453 YBR249C RiBi 
C1_01330C_A DUT1 CAL0000195525 DUT1 YBR252W S000000456 YBR252W RiBi 
C1_05060W_A REI1 CAL0000177865 REI1 YBR267W S000000471 YBR267W RiBi 
C2_02620W_A  CAL0000192813 SDH8 YBR269C S000000473 YBR269C iESR 
C1_05530C_A SSH1 CAL0000193960 SSH1 YBR283C S000000487 YBR283C RiBi 
CR_07480W_A  CAL0000180922 YBR287W YBR287W S000000491 YBR287W iESR 
C2_02710C_A  CAL0000178916 RRP7 YCL031C S000000536 YCL031C RiBi 
CR_07150W_A GLK1 CAL0000189805 GLK1 YCL040W S000000545 YCL040W iESR 
C5_01410C_A  CAL0000201797 EMC1 YCL045C S000000550 YCL045C RiBi 
C6_04160C_A SPB1 CAL0000201177 SPB1 YCL054W S000000559 YCL054W RiBi 
C1_11420W_A KRR1 CAL0000200947 KRR1 YCL059C S000000564 YCL059C RiBi 
CR_05380C_A YCP4 CAL0000193139 YCP4 YCR004C S000000597 YCR004C iESR 
C3_07600W_A  CAL0000193391 YCR016W YCR016W S000000609 YCR016W RiBi 
C1_12790C_A FEN1 CAL0000190970 ELO2 YCR034W S000000630 YCR034W RiBi 
C1_06540C_A  CAL0000184319 RRP43 YCR035C S000000631 YCR035C RiBi 
C5_02270W_A THR4 CAL0000193606 THR4 YCR053W S000000649 YCR053W RiBi 
CR_00800C_A PWP2 CAL0000174443 PWP2 YCR057C S000000653 YCR057C RiBi 
C1_10360C_A  CAL0000189087 YCR061W YCR061W S000000657 YCR061W iESR 
C4_05010W_A  CAL0000180486 RSA4 YCR072C S000000668 YCR072C RiBi 
58 
C2_10240W_A GPD1 CAL0000200026 GPD1 YDL022W S000002180 YDL022W iESR 
C3_05160C_A  CAL0000186628 DBP10 YDL031W S000002189 YDL031W RiBi 
C1_07500C_A LHP1 CAL0000195360 LHP1 YDL051W S000002209 YDL051W RiBi 
CR_08490W_A TSR1 CAL0000183541 TSR1 YDL060W S000002218 YDL060W RiBi 
CR_08500W_A  CAL0000176600 SYO1 YDL063C S000002221 YDL063C RiBi 
C1_03010W_A RPP1A CAL0000178222 RPP1A YDL081C S000002239 YDL081C RP 
C1_03020C_A RPL13 CAL0000201310 RPL13A YDL082W S000002240 YDL082W RP 
C4_00220C_A SUB2 CAL0000200240 SUB2 YDL084W S000002242 YDL084W RiBi 
C4_03770W_A  CAL0000188816 TMA17 YDL110C S000002268 YDL110C iESR 
C4_03840C_A RRP42 CAL0000183621 RRP42 YDL111C S000002269 YDL111C RiBi 
C7_03350C_A  CAL0000193623 YDL124W YDL124W S000002282 YDL124W iESR 
C7_03920C_A RPP1B CAL0000195487 RPP1B YDL130W S000002288 YDL130W 
SGD-annotated 
RP 
C4_02780W_A  CAL0000192278 CCT4 YDL143W S000002302 YDL143W RiBi 
C4_02800W_A RPC53 CAL0000175841 RPC53 YDL150W S000002309 YDL150W RiBi 
C4_02790C_A SAS10 CAL0000185070 SAS10 YDL153C S000002312 YDL153C RiBi 
C1_08000W_A NRP1 CAL0000187528 NRP1 YDL167C S000002326 YDL167C RiBi 
C3_04960W_A RPL35 CAL0000191177 RPL35A YDL191W S000002350 YDL191W RP 
CR_03850W_A HGT3 CAL0000177617 YDL199C YDL199C S000002358 YDL199C iESR 
C4_04810C_A  CAL0000183898 TRM8 YDL201W S000002360 YDL201W RiBi 
C7_02240W_A FMP45 CAL0000192127 FMP45 YDL222C S000002381 YDL222C iESR 
CR_00560W_A NTH1 CAL0000200632 NTH1 YDR001C S000002408 YDR001C iESR 
C1_14110C_A RPL4B CAL0000176632 RPL4B YDR012W S000002419 YDR012W RP 
C3_02780W_A SES1 CAL0000183348 SES1 YDR023W S000002430 YDR023W RiBi 
C5_01540W_A  CAL0000187802 RPS11A YDR025W S000002432 YDR025W RP 
CR_05390W_A PST3 CAL0000180388 PST2 YDR032C S000002439 YDR032C iESR 
C3_07410C_A KRS1 CAL0000185145 KRS1 YDR037W S000002444 YDR037W RiBi 
C6_00650C_A RPS13 CAL0000187390 RPS13 YDR064W S000002471 YDR064W RP 
C1_03380W_A TPS2 CAL0000193855 TPS2 YDR074W S000002481 YDR074W iESR 
C2_08480W_A RRP8 CAL0000191512 RRP8 YDR083W S000002490 YDR083W RiBi 
C3_06760W_A  CAL0000174798 RRP1 YDR087C S000002494 YDR087C RiBi 
C1_03350C_A RLI1 CAL0000178640 RLI1 YDR091C S000002498 YDR091C RiBi 
C1_13170C_A MSH6 CAL0000192796 MSH6 YDR097C S000002504 YDR097C RiBi 
C1_03230C_A ARX1 CAL0000194302 ARX1 YDR101C S000002508 YDR101C RiBi 
CR_00900W_A TRM1 CAL0000179806 TRM1 YDR120C S000002527 YDR120C RiBi 
C7_01420W_A GIR2 CAL0000185013 GIR2 YDR152W S000002559 YDR152W RiBi 
C1_13370W_A  CAL0000179941 YDR161W YDR161W S000002568 YDR161W RiBi 
C7_02340C_A  CAL0000187643 TRM82 YDR165W S000002572 YDR165W RiBi 
C2_09010W_A STB3 CAL0000192161 STB3 YDR169C S000002576 YDR169C iESR 
C2_09720W_A SUP35 CAL0000176993 SUP35 YDR172W S000002579 YDR172W RiBi 
C4_07150W_A  CAL0000196526 ATC1 YDR184C S000002592 YDR184C RiBi 
59 
C4_06800W_A  CAL0000181596 RVB1 YDR190C S000002598 YDR190C RiBi 
C1_03160C_A COQ4 CAL0000193093 COQ4 YDR204W S000002612 YDR204W iESR 
C1_08600C_A GCD6 CAL0000183518 GCD6 YDR211W S000002619 YDR211W RiBi 
C4_04800W_A  CAL0000195123 RTN1 YDR233C S000002641 YDR233C RiBi 
C1_04570C_A CHL4 CAL0000188322 CHL4 YDR254W S000002662 YDR254W iESR 
C1_04560W_A  CAL0000175041 RMD5 YDR255C S000002663 YDR255C iESR 
C2_03390C_A HSP78 CAL0000189244 HSP78 YDR258C S000002666 YDR258C iESR 
C2_09260C_A GLO2 CAL0000189186 GLO2 YDR272W S000002680 YDR272W iESR 
C2_09160W_A  CAL0000176918 RRP45 YDR280W S000002688 YDR280W RiBi 
C3_03200C_A  CAL0000193978 YDR286C YDR286C S000002694 YDR286C iESR 
CR_10580W_A PRO1 CAL0000178490 PRO1 YDR300C S000002708 YDR300C RiBi 
CR_10170C_A  CAL0000197030 ASP1 YDR321W S000002729 YDR321W RiBi 
C3_02130W_A UTP4 CAL0000184134 UTP4 YDR324C S000002732 YDR324C RiBi 
C5_03920C_A  CAL0000182246 FCF1 YDR339C S000002747 YDR339C RiBi 
C1_01530C_A  CAL0000176283 YDR341C YDR341C S000002749 YDR341C RiBi 
C1_00400W_A SVF1 CAL0000182395 SVF1 YDR346C S000002754 YDR346C RiBi 
C1_12760W_A  CAL0000174555 BCP1 YDR361C S000002769 YDR361C RiBi 
C1_10970W_A  CAL0000194444 ESF1 YDR365C S000002773 YDR365C RiBi 
CR_06860C_A ARO10 CAL0000184409 ARO10 YDR380W S000002788 YDR380W iESR 
C3_04680W_A RPP2B CAL0000199315 RPP2B YDR382W S000002790 YDR382W RP 
CR_10240W_A UTP5 CAL0000191285 UTP5 YDR398W S000002806 YDR398W RiBi 
C1_07950C_A  CAL0000175073 RRP17 YDR412W S000002820 YDR412W RiBi 
C1_14260C_A TIF35 CAL0000193017 TIF35 YDR429C S000002837 YDR429C RiBi 
C3_06300W_A DOT1 CAL0000184097 DOT1 YDR440W S000002848 YDR440W RiBi 
C1_10870W_A RPS17B CAL0000195565 RPS17B YDR447C S000002855 YDR447C RP 
C1_10880W_A  CAL0000174108 UTP6 YDR449C S000002857 YDR449C RiBi 
C5_03790W_A GUK1 CAL0000178615 GUK1 YDR454C S000002862 YDR454C RP 
C5_00680W_A RMT2 CAL0000180017 RMT2 YDR465C S000002873 YDR465C RiBi 
C2_05160C_A  CAL0000178700 PUF6 YDR496C S000002904 YDR496C RiBi 
C1_11360W_A RPL37B CAL0000198698 RPL37B YDR500C S000002908 YDR500C RP 
C2_05020W_A  CAL0000192157 EMI1 YDR512C S000002920 YDR512C iESR 
C1_00490C_A TTR1 CAL0000190988 GRX2 YDR513W S000002921 YDR513W iESR 
C3_02610C_A GLX3 CAL0000194072 HSP31 YDR533C S000002941 YDR533C iESR 
C6_03340C_A GLC3 CAL0000188820 GLC3 YEL011W S000000737 YEL011W iESR 
C1_01830C_A UBC8 CAL0000197909 UBC8 YEL012W S000000738 YEL012W iESR 
C3_04380C_A  CAL0000183109 SNU13 YEL026W S000000752 YEL026W RP 
C3_01730C_A UTR2 CAL0000175165 UTR2 YEL040W S000000766 YEL040W RiBi 
C3_06120C_A GDA1 CAL0000196532 GDA1 YEL042W S000000768 YEL042W RiBi 
C3_02110W_A RPL12 CAL0000181929 RPL12A YEL054C S000000780 YEL054C RP 
C7_03860W_A  CAL0000175297 PRB1 YEL060C S000000786 YEL060C iESR 
C4_06210C_A  CAL0000184634 NUG1 YER006W S000000808 YER006W RiBi 
60 
C1_10100C_A NTF2 CAL0000201779 NTF2 YER009W S000000811 YER009W RiBi 
C5_02170C_A GCD11 CAL0000197613 GCD11 YER025W S000000827 YER025W RP 
C2_08000C_A KRE30 CAL0000185948 ARB1 YER036C S000000838 YER036C RiBi 
C5_04270C_A SAH1 CAL0000201641 SAH1 YER043C S000000845 YER043C RiBi 
C4_05460C_A OFD1 CAL0000194379 TPA1 YER049W S000000851 YER049W RiBi 
C2_09590C_A  CAL0000177748 PIC2 YER053C S000000855 YER053C iESR 
C2_03160C_A RNR1 CAL0000199428 RNR1 YER070W S000000872 YER070W RiBi 
C1_09710C_A  CAL0000181309 UTP7 YER082C S000000884 YER082C RiBi 
C2_05610C_A RPS8A CAL0000186765 RPS8B YER102W S000000904 YER102W RP 
C1_13480W_A HSP70 CAL0000184706 SSA4 YER103W S000000905 YER103W iESR 
C1_05630C_A  CAL0000182139 KAP123 YER110C S000000912 YER110C RiBi 
C6_02070C_A RPL23A CAL0000187999 RPL23B YER117W S000000919 YER117W RP 
C1_09140C_A SSU81 CAL0000185371 SHO1 YER118C S000000920 YER118C RiBi 
C6_04110W_A  CAL0000175251 AVT6 YER119C S000000921 YER119C iESR 
C3_06380W_A NSA2 CAL0000197650 NSA2 YER126C S000000928 YER126C RiBi 
C3_06370C_A  CAL0000175453 LCP5 YER127W S000000929 YER127W RiBi 
C6_00720C_A COX15 CAL0000185068 COX15 YER141W S000000943 YER141W iESR 
C2_08420W_A  CAL0000200044 MAG1 YER142C S000000944 YER142C iESR 
C1_03370W_A  CAL0000195952 PAB1 YER165W S000000967 YER165W RiBi 
C5_01600C_A SPB4 CAL0000185825 SPB4 YFL002C S000001894 YFL002C RiBi 
C5_02110W_A  CAL0000180850 HSP12 YFL014W S000001880 YFL014W iESR 
C1_02710W_A FRS2 CAL0000201701 FRS2 YFL022C S000001872 YFL022C RiBi 
C5_02010C_A  CAL0000185005 BUD27 YFL023W S000001871 YFL023W RiBi 
C4_04390W_A  CAL0000196794 RPL22B YFL034C-A S000006436 YFL034C-A 
SGD-annotated 
RP 
C1_02440C_A  CAL0000186385 OTU1 YFL044C S000001850 YFL044C iESR 
C1_02480W_A PMM1 CAL0000183926 SEC53 YFL045C S000001849 YFL045C RiBi 
C3_02040C_A  CAL0000180322 LOC1 YFR001W S000001897 YFR001W RiBi 
C1_11060C_A RPL2 CAL0000174265 RPL2A YFR031C-A S000002104 YFR031C-A RP 
C1_11040W_A RPL29 CAL0000175799 RPL29 YFR032C-A S000006437 YFR032C-A 
SGD-annotated 
RP 
C6_04580W_A HXK1 CAL0000186127 HXK1 YFR053C S000001949 YFR053C iESR 
C3_01250W_A PMC1 CAL0000196416 PMC1 YGL006W S000002974 YGL006W iESR 
C3_00720W_A PMA1 CAL0000187161 PMA1 YGL008C S000002976 YGL008C RiBi 
C2_01660C_A  CAL0000177781 MPO1 YGL010W S000002978 YGL010W iESR 
C1_11000C_A  CAL0000173953 CGR1 YGL029W S000002997 YGL029W RiBi 
C4_04900W_A RPL30 CAL0000189848 RPL30 YGL030W S000002998 YGL030W RP 
C4_04890C_A RPL24A CAL0000190222 RPL24A YGL031C S000002999 YGL031C RP 
C7_03520W_A PNC1 CAL0000183035 PNC1 YGL037C S000003005 YGL037C iESR 
C2_07200W_A  CAL0000191376 RPB9 YGL070C S000003038 YGL070C RiBi 
C1_05720W_A  CAL0000182421 RPL7A YGL076C S000003044 YGL076C RP 
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C1_10030W_A DBP3 CAL0000185988 DBP3 YGL078C S000003046 YGL078C RiBi 
C1_12650C_A  CAL0000191589 MMS2 YGL087C S000003055 YGL087C iESR 
C7_02040C_A CUP9 CAL0000195705 TOS8 YGL096W S000003064 YGL096W iESR 
C7_02780W_A  CAL0000200421 SRM1 YGL097W S000003065 YGL097W RiBi 
C6_02230W_A  CAL0000183488 LSG1 YGL099W S000003067 YGL099W RiBi 
CR_03030C_A RPL28 CAL0000198266 RPL28 YGL103W S000003071 YGL103W RP 
C2_07960C_A NSA1 CAL0000184567 NSA1 YGL111W S000003079 YGL111W RiBi 
C3_01560W_A  CAL0000191988 PRP43 YGL120C S000003088 YGL120C RiBi 
C1_01480C_A RPS21 CAL0000191073 RPS2 YGL123W S000003091 YGL123W RP 
CR_07710W_A ARO2 CAL0000185781 ARO2 YGL148W S000003116 YGL148W RiBi 
C4_02360W_A AMS1 CAL0000179816 AMS1 YGL156W S000003124 YGL156W iESR 
C7_00330C_A  CAL0000197105 SUA5 YGL169W S000003137 YGL169W RiBi 
C1_12600C_A CHR1 CAL0000178978 ROK1 YGL171W S000003139 YGL171W RiBi 
C4_04450C_A ATG1 CAL0000188572 ATG1 YGL180W S000003148 YGL180W iESR 
C2_01610C_A RPS26A CAL0000180001 RPS26A YGL189C S000003157 YGL189C RP 
C6_03890C_A SKI8 CAL0000201104 SKI8 YGL213C S000003181 YGL213C RiBi 
C1_07700C_A VRG4 CAL0000182900 VRG4 YGL225W S000003193 YGL225W RiBi 
C5_02290W_A PDE1 CAL0000177603 PDE1 YGL248W S000003217 YGL248W iESR 
C2_04190C_A UGA1 CAL0000181031 UGA1 YGR019W S000003251 YGR019W iESR 
C1_02330C_A  CAL0000201086 RPL26B YGR034W S000003266 YGR034W RP 
C1_02430C_A  CAL0000199029 YGR054W YGR054W S000003286 YGR054W RiBi 
C3_05120C_A  CAL0000183866 PAC10 YGR078C S000003310 YGR078C RiBi 
C2_06850W_A  CAL0000183209 SLX9 YGR081C S000003313 YGR081C RiBi 
C3_07250W_A GCD2 CAL0000182407 GCD2 YGR083C S000003315 YGR083C RiBi 
C2_06810C_A RPL11 CAL0000192242 RPL11B YGR085C S000003317 YGR085C RP 
C2_06640C_A VAS1 CAL0000181624 VAS1 YGR094W S000003326 YGR094W RiBi 
C2_09320C_A PES1 CAL0000200824 NOP7 YGR103W S000003335 YGR103W RiBi 
C3_01710C_A PPT1 CAL0000195801 PPT1 YGR123C S000003355 YGR123C RiBi 
C2_09060C_A ASN1 CAL0000188342 ASN2 YGR124W S000003356 YGR124W RiBi 
CR_03260W_A  CAL0000196868 YGR127W YGR127W S000003359 YGR127W iESR 
C3_00330W_A UTP8 CAL0000200844 UTP8 YGR128C S000003360 YGR128C RiBi 
C7_03540C_A ENP2 CAL0000177364 ENP2 YGR145W S000003377 YGR145W RiBi 
C1_10460W_A  CAL0000184780 YGR149W YGR149W S000003381 YGR149W iESR 
CR_02140W_A RSR1 CAL0000199219 RSR1 YGR152C S000003384 YGR152C RiBi 
CR_02550C_A  CAL0000191642 MTR3 YGR158C S000003390 YGR158C RiBi 
CR_00290W_A  CAL0000200149 RTS3 YGR161C S000003393 YGR161C iESR 
C2_08760C_A TIF4631 CAL0000188458 TIF4631 YGR162W S000003394 YGR162W RiBi 
C5_04900C_A  CAL0000184764 RBG2 YGR173W S000003405 YGR173W RiBi 
C4_02980W_A TYS1 CAL0000188062 TYS1 YGR185C S000003417 YGR185C RiBi 
C4_02050W_A HGH1 CAL0000178023 HGH1 YGR187C S000003419 YGR187C RiBi 
C4_05300W_A XKS1 CAL0000191735 XKS1 YGR194C S000003426 YGR194C iESR 
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C4_02090C_A  CAL0000180234 SKI6 YGR195W S000003427 YGR195W RiBi 
C4_02850W_A  CAL0000181143 ELP2 YGR200C S000003432 YGR200C RiBi 
C3_05370C_A YST1 CAL0000191976 RPS0A YGR214W S000003446 YGR214W RP 
C1_07870C_A SMI1 CAL0000199204 SMI1 YGR229C S000003461 YGR229C RiBi 
C5_04960W_A  CAL0000181504 YGR237C YGR237C S000003469 YGR237C iESR 
CR_05660W_A SDA1 CAL0000201072 SDA1 YGR245C S000003477 YGR245C RiBi 
C5_04840C_A  CAL0000189299 NOP19 YGR251W S000003483 YGR251W RiBi 
C5_04700C_A MES1 CAL0000178172 MES1 YGR264C S000003496 YGR264C RiBi 
C4_04520W_A  CAL0000197682 PXR1 YGR280C S000003512 YGR280C RiBi 
C4_02870C_A ZUO1 CAL0000192667 ZUO1 YGR285C S000003517 YGR285C RiBi 
C1_13050W_A RPL14 CAL0000179395 RPL14B YHL001W S000000993 YHL001W RP 
C2_02510W_A PRS1 CAL0000176742 PRS3 YHL011C S000001003 YHL011C RiBi 
C5_01110W_A  CAL0000189600 OTU2 YHL013C S000001005 YHL013C RiBi 
CR_08150W_A RPS20 CAL0000185871 RPS20 YHL015W S000001007 YHL015W 
SGD-annotated 
RP 
C7_04310C_A  CAL0000176874 AIM17 YHL021C S000001013 YHL021C iESR 
C1_12390C_A RPL27A CAL0000176884 RPL27A YHR010W S000001052 YHR010W RP 
CR_10400W_A  CAL0000201001 ARD1 YHR013C S000001055 YHR013C RiBi 
C7_03670W_A DED81 CAL0000197236 DED81 YHR019C S000001061 YHR019C RiBi 
C7_03660C_A  CAL0000176548 YHR020W YHR020W S000001062 YHR020W RiBi 
CR_07630C_A RPS27 CAL0000200692 RPS27B YHR021C S000001063 YHR021C RP 
C5_00650C_A THR1 CAL0000196189 THR1 YHR025W S000001067 YHR025W RiBi 
C1_13280C_A  CAL0000187987 VMA16 YHR026W S000001068 YHR026W RiBi 
C4_03180W_A NCP1 CAL0000197218 NCP1 YHR042W S000001084 YHR042W RiBi 
C6_01170W_A CIC1 CAL0000187983 CIC1 YHR052W S000001094 YHR052W RiBi 
C4_04700W_A SSZ1 CAL0000182719 SSZ1 YHR064C S000001106 YHR064C RiBi 
CR_09740W_A  CAL0000176052 RRP3 YHR065C S000001107 YHR065C RiBi 
CR_09730C_A SSF1 CAL0000187750 SSF1 YHR066W S000001108 YHR066W RiBi 
C3_02180C_A  CAL0000180114 DYS1 YHR068W S000001110 YHR068W RiBi 
C2_07630C_A  CAL0000176228 RTC3 YHR087W S000001129 YHR087W iESR 
C4_03270W_A RPF1 CAL0000187860 RPF1 YHR088W S000001130 YHR088W RiBi 
C1_11550W_A GAR1 CAL0000187800 GAR1 YHR089C S000001131 YHR089C RiBi 
C5_02930C_A GRE3 CAL0000192827 GRE3 YHR104W S000001146 YHR104W iESR 
CR_09010C_A  CAL0000185607 YHR112C YHR112C S000001154 YHR112C iESR 
C5_03390C_A FUR1 CAL0000201707 FUR1 YHR128W S000001170 YHR128W RP 
C4_05560C_A ARO9 CAL0000197694 ARO9 YHR137W S000001179 YHR137W iESR 
C4_02340W_A  CAL0000188954 YHR138C YHR138C S000001180 YHR138C iESR 
C1_14390W_A RPC10 CAL0000192095 RPC10 YHR143W-A S000001185 YHR143W-A RiBi 
C1_14310W_A  CAL0000182387 DCD1 YHR144C S000001187 YHR144C RiBi 
CR_00460C_A  CAL0000189738 IMP3 YHR148W S000001191 YHR148W RiBi 
CR_05630W_A DBP8 CAL0000181153 DBP8 YHR169W S000001212 YHR169W RiBi 
63 
CR_06720W_A NMD3 CAL0000185434 NMD3 YHR170W S000001213 YHR170W RiBi 
CR_06730W_A APG7 CAL0000178896 ATG7 YHR171W S000001214 YHR171W iESR 
C3_04140C_A EGD2 CAL0000185584 EGD2 YHR193C S000001236 YHR193C RiBi 
C3_07750W_A UTP9 CAL0000175459 UTP9 YHR196W S000001239 YHR196W RiBi 
C4_05230C_A  CAL0000185245 RIX1 YHR197W S000001240 YHR197W RiBi 
C4_05650W_A  CAL0000182332 FAF1 YIL019W S000001281 YIL019W RiBi 
C4_05640C_A  CAL0000175514 HIS6 YIL020C S000001282 YIL020C RiBi 
C4_05630W_A  CAL0000186561 RPB3 YIL021W S000001283 YIL021W RiBi 
C1_06890C_A  CAL0000185373 RPL34B YIL052C S000001314 YIL052C RP 
C3_00090W_A RPS24 CAL0000180342 RPS24B YIL069C S000001331 YIL069C 
SGD-annotated 
RP 
C5_00110C_A THS1 CAL0000177380 THS1 YIL078W S000001340 YIL078W RiBi 
C3_05860C_A  CAL0000182639 BMT5 YIL096C S000001358 YIL096C RiBi 
C3_05850W_A  CAL0000193350 FYV10 YIL097W S000001359 YIL097W iESR 
C3_01320C_A SGA1 CAL0000178932 SGA1 YIL099W S000001361 YIL099W iESR 
C2_05860C_A  CAL0000190238 XBP1 YIL101C S000001363 YIL101C iESR 
C2_05830C_A  CAL0000201076 SHQ1 YIL104C S000001366 YIL104C RiBi 
C1_08950W_A PFK26 CAL0000176014 PFK26 YIL107C S000001369 YIL107C iESR 
C1_09040C_A  CAL0000175693 HPM1 YIL110W S000001372 YIL110W RiBi 
CR_04210C_A QDR1 CAL0000179875 QDR1 YIL120W S000001382 YIL120W iESR 
C3_00900C_A AYR1 CAL0000181438 AYR1 YIL124W S000001386 YIL124W iESR 
C3_01430W_A  CAL0000186307 RRT14 YIL127C S000001389 YIL127C RiBi 
C1_00180W_A RPL16A CAL0000175593 RPL16A YIL133C S000001395 YIL133C RP 
CR_01470W_A CSP37 CAL0000182669 OM45 YIL136W S000001398 YIL136W iESR 
C5_05340W_A  CAL0000180910 SQT1 YIR012W S000001451 YIR012W RiBi 
CR_03570C_A YVH1 CAL0000184045 YVH1 YIR026C S000001465 YIR026C RiBi 
C6_00850W_A  CAL0000196844 HYR1 YIR037W S000001476 YIR037W iESR 
C3_03600C_A GTT12 CAL0000179604 GTT1 YIR038C S000001477 YIR038C iESR 
C3_05530W_A OST1 CAL0000177262 OST1 YJL002C S000003539 YJL002C RiBi 
C5_05120W_A CCT3 CAL0000198447 CCT3 YJL014W S000003551 YJL014W RiBi 
C4_02830C_A HCA4 CAL0000199884 HCA4 YJL033W S000003570 YJL033W RiBi 
C7_03400C_A  CAL0000198236 MTR4 YJL050W S000003586 YJL050W RiBi 
C1_05370C_A  CAL0000176582 IKS1 YJL057C S000003593 YJL057C iESR 
CR_03120W_A  CAL0000191885 MPM1 YJL066C S000003602 YJL066C iESR 
CR_09670C_A  CAL0000178864 YJL068C YJL068C S000003604 YJL068C iESR 
C7_04190C_A UTP18 CAL0000175893 UTP18 YJL069C S000003605 YJL069C RiBi 
C1_11860W_A  CAL0000181643 SCP160 YJL080C S000003616 YJL080C RiBi 
C1_07170C_A ZCF23 CAL0000175205 GSM1 YJL103C S000003639 YJL103C iESR 
C1_14080W_A  CAL0000180258 UTP10 YJL109C S000003645 YJL109C RiBi 
C7_00160C_A  CAL0000182219 ALB1 YJL122W S000003658 YJL122W RiBi 
CR_08940W_A  CAL0000194641 GCD14 YJL125C S000003661 YJL125C RiBi 
64 
C1_01370C_A RPS21B CAL0000190545 RPS21B YJL136C S000003672 YJL136C RP 
C1_01350C_A TIF CAL0000186279 TIF2 YJL138C S000003674 YJL138C RP 
C2_04660C_A YAK1 CAL0000193813 YAK1 YJL141C S000003677 YJL141C iESR 
C1_10260C_A RPA34 CAL0000179921 RPA34 YJL148W S000003684 YJL148W RiBi 
CR_08550W_A  CAL0000186425 FBP26 YJL155C S000003691 YJL155C iESR 
C3_05380W_A  CAL0000179271 YJL163C YJL163C S000003699 YJL163C iESR 
C2_04600C_A RPL17B CAL0000193181 RPL17B YJL177W S000003713 YJL177W RP 
C1_02400C_A MNN11 CAL0000193393 MNN11 YJL183W S000003719 YJL183W RiBi 
C1_06470W_A  CAL0000189989 RPL39 YJL189W S000003725 YJL189W RP 
C1_06460C_A RPS22A CAL0000188584 RPS22A YJL190C S000003726 YJL190C RP 
C1_06450C_A RPS14B CAL0000196584 RPS14B YJL191W S000003727 YJL191W RP 
C5_00280C_A  CAL0000174323 NUC1 YJL208C S000003744 YJL208C RiBi 
C2_00070C_A MPP10 CAL0000175136 MPP10 YJR002W S000003762 YJR002W RiBi 
C4_05310W_A  CAL0000183261 YJR003C YJR003C S000003763 YJR003C RiBi 
C1_06960W_A SUI2 CAL0000201409 SUI2 YJR007W S000003767 YJR007W RiBi 
C1_14030W_A  CAL0000191113 MHO1 YJR008W S000003768 YJR008W iESR 
C4_00770C_A  CAL0000192770 TMA22 YJR014W S000003775 YJR014W RiBi 
CR_05440W_A  CAL0000184857 BNA1 YJR025C S000003786 YJR025C iESR 
C3_04370C_A  CAL0000187255 URB2 YJR041C S000003802 YJR041C RiBi 
C1_05850W_A POL32 CAL0000193896 POL32 YJR043C S000003804 YJR043C RiBi 
C6_01710C_A PTK2 CAL0000186778 PTK2 YJR059W S000003820 YJR059W iESR 
C2_07300C_A RPA12 CAL0000195650 RPA12 YJR063W S000003824 YJR063W RiBi 
C2_07310W_A CCT5 CAL0000189768 CCT5 YJR064W S000003825 YJR064W RiBi 
C2_07290W_A  CAL0000183521 LIA1 YJR070C S000003831 YJR070C RiBi 
C3_06860C_A  CAL0000185942 YJR096W YJR096W S000003857 YJR096W iESR 
C4_02320C_A SOD1 CAL0000185037 SOD1 YJR104C S000003865 YJR104C iESR 
C5_03070W_A RPS5 CAL0000175293 RPS5 YJR123W S000003884 YJR123W RP 
C5_03940C_A  CAL0000181747 YJR124C YJR124C S000003885 YJR124C RiBi 
C2_06100W_A PMT4 CAL0000192933 PMT4 YJR143C S000003904 YJR143C RiBi 
C1_01640W_A RPS42 CAL0000191446 RPS4A YJR145C S000003906 YJR145C RP 
C6_02770W_A MRT4 CAL0000181896 MRT4 YKL009W S000001492 YKL009W RiBi 
C4_05330C_A  CAL0000187814 MAK11 YKL021C S000001504 YKL021C RiBi 
CR_04660C_A UGP1 CAL0000175518 UGP1 YKL035W S000001518 YKL035W iESR 
CR_00860C_A TMA19 CAL0000181023 TMA19 YKL056C S000001539 YKL056C RP 
C5_02890W_A YNK1 CAL0000191707 YNK1 YKL067W S000001550 YKL067W iESR 
C6_01040C_A  CAL0000190791 DHR2 YKL078W S000001561 YKL078W RiBi 
C2_08190W_A VMA5 CAL0000198252 VMA5 YKL080W S000001563 YKL080W RiBi 
C2_08180C_A  CAL0000200640 RRP14 YKL082C S000001565 YKL082C RiBi 
CR_03360W_A  CAL0000180806 UTP11 YKL099C S000001582 YKL099C RiBi 
C3_02170C_A LAP41 CAL0000183019 APE1 YKL103C S000001586 YKL103C iESR 
CR_03370C_A KTI12 CAL0000192073 KTI12 YKL110C S000001593 YKL110C RiBi 
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C1_01940C_A  CAL0000197941 SRP21 YKL122C S000001605 YKL122C RiBi 
C7_03890C_A  CAL0000180066 SSH4 YKL124W S000001607 YKL124W iESR 
C4_04430W_A MRP8 CAL0000198349 MRP8 YKL142W S000001625 YKL142W iESR 
CR_10650W_A LTV1 CAL0000196926 LTV1 YKL143W S000001626 YKL143W RiBi 
C1_05230W_A  CAL0000199486 RPC25 YKL144C S000001627 YKL144C RiBi 
C6_02040W_A MCR1 CAL0000182452 MCR1 YKL150W S000001633 YKL150W iESR 
C6_02030C_A  CAL0000185966 YKL151C YKL151C S000001634 YKL151C iESR 
CR_07660C_A  CAL0000180632 SRP102 YKL154W S000001637 YKL154W RiBi 
C1_05510C_A RPS27A CAL0000198357 RPS27A YKL156W S000001639 YKL156W RP 
C2_04570W_A  CAL0000183510 EBP2 YKL172W S000001655 YKL172W RiBi 
C5_00260W_A  CAL0000189135 PRS1 YKL181W S000001664 YKL181W RiBi 
C1_12100C_A PXA2 CAL0000196592 PXA2 YKL188C S000001671 YKL188C iESR 
C2_04020C_A SDS22 CAL0000176734 SDS22 YKL193C S000001676 YKL193C iESR 
C7_04200C_A  CAL0000200169 LOS1 YKL205W S000001688 YKL205W RiBi 
C3_00810C_A FOX2 CAL0000176075 FOX2 YKR009C S000001717 YKR009C iESR 
C7_01200C_A DBP7 CAL0000199731 DBP7 YKR024C S000001732 YKR024C RiBi 
C7_01210C_A  CAL0000182770 RPC37 YKR025W S000001733 YKR025W RiBi 
C7_01220W_A GCN3 CAL0000186383 GCN3 YKR026C S000001734 YKR026C RiBi 
C2_07420W_A  CAL0000182609 SHB17 YKR043C S000001751 YKR043C RiBi 
C1_01380C_A TRM2 CAL0000192336 TRM2 YKR056W S000001764 YKR056W RiBi 
C2_04700C_A  CAL0000194786 UTP30 YKR060W S000001768 YKR060W RiBi 
C3_02480C_A CCP1 CAL0000199533 CCP1 YKR066C S000001774 YKR066C iESR 
C2_02890W_A SCT2 CAL0000191565 GPT2 YKR067W S000001775 YKR067W iESR 
CR_02130W_A ECM4 CAL0000196854 ECM4 YKR076W S000001784 YKR076W iESR 
C3_00420W_A  CAL0000186672 TRZ1 YKR079C S000001787 YKR079C RiBi 
C2_05230C_A RPF2 CAL0000180822 RPF2 YKR081C S000001789 YKR081C RiBi 
CR_02980C_A SRP40 CAL0000197163 SRP40 YKR092C S000001800 YKR092C RiBi 
CR_10550W_A DRS1 CAL0000182242 DRS1 YLL008W S000003931 YLL008W RiBi 
C3_00560C_A SOF1 CAL0000196031 SOF1 YLL011W S000003934 YLL011W RiBi 
C1_13470W_A KNS1 CAL0000194707 KNS1 YLL019C S000003942 YLL019C iESR 
CR_08250C_A HSP104 CAL0000200274 HSP104 YLL026W S000003949 YLL026W iESR 
C5_02120C_A RIX7 CAL0000179059 RIX7 YLL034C S000003957 YLL034C RiBi 
CR_06450W_A  CAL0000182248 GRC3 YLL035W S000003958 YLL035W RiBi 
C3_07480W_A  CAL0000186688 PRP19 YLL036C S000003959 YLL036C RiBi 
C3_07270C_A UBI4 CAL0000186339 UBI4 YLL039C S000003962 YLL039C iESR 
C3_05240C_A RPL8B CAL0000183492 RPL8B YLL045C S000003968 YLL045C RP 
C7_00260C_A  CAL0000199507 YLR001C YLR001C S000003991 YLR001C iESR 
C7_03850W_A  CAL0000177493 NOC3 YLR002C S000003992 YLR002C RiBi 
C1_07790C_A  CAL0000195062 CMS1 YLR003C S000003993 YLR003C RiBi 
C4_00510C_A RLP24 CAL0000179590 RLP24 YLR009W S000003999 YLR009W RP 
C3_03790W_A MEU1 CAL0000179927 MEU1 YLR017W S000004007 YLR017W RiBi 
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C4_06570C_A PDC11 CAL0000201027 PDC1 YLR044C S000004034 YLR044C RiBi 
C3_07800C_A  CAL0000179596 FCF2 YLR051C S000004041 YLR051C RiBi 
CR_01760C_A FRS1 CAL0000190210 FRS1 YLR060W S000004050 YLR060W RiBi 
CR_01780W_A  CAL0000181125 BMT6 YLR063W S000004053 YLR063W RiBi 
C1_01950C_A  CAL0000175736 ENV10 YLR065C S000004055 YLR065C RiBi 
C1_02450C_A  CAL0000190982 BUD20 YLR074C S000004064 YLR074C RiBi 
C1_02460W_A RPL10 CAL0000194016 RPL10 YLR075W S000004065 YLR075W RP 
CR_07180W_A EMP46 CAL0000179572 EMP46 YLR080W S000004070 YLR080W iESR 
C4_02550C_A EMP70 CAL0000181076 EMP70 YLR083C S000004073 YLR083C RiBi 
C1_08290C_A DIP2 CAL0000188650 DIP2 YLR129W S000004119 YLR129W RiBi 
C5_02600W_A PUT1 CAL0000197353 PUT1 YLR142W S000004132 YLR142W iESR 
C1_13330C_A  CAL0000192204 SPE4 YLR146C S000004136 YLR146C RiBi 
C7_03280C_A  CAL0000191424 YLR149C YLR149C S000004139 YLR149C iESR 
C3_04810C_A  CAL0000197338 STM1 YLR150W S000004140 YLR150W RiBi 
C4_07180W_A UBI3 CAL0000178202 RPS31 YLR167W S000004157 YLR167W RP 
C5_03700C_A  CAL0000183474 DPH5 YLR172C S000004162 YLR172C RiBi 
C1_10620W_A  CAL0000194674 CBF5 YLR175W S000004165 YLR175W RiBi 
C5_00930C_A TFS1 CAL0000201755 TFS1 YLR178C S000004168 YLR178C iESR 
C1_11350C_A TOS4 CAL0000194861 TOS4 YLR183C S000004173 YLR183C RiBi 
C1_11380W_A NEP1 CAL0000197320 EMG1 YLR186W S000004176 YLR186W RiBi 
C4_01450W_A PWP1 CAL0000198308 PWP1 YLR196W S000004186 YLR196W RiBi 
CR_09950C_A SIK1 CAL0000178436 NOP56 YLR197W S000004187 YLR197W RiBi 
C1_04710C_A  CAL0000175312 RSA3 YLR221C S000004211 YLR221C RiBi 
C5_02550C_A UTP13 CAL0000184822 UTP13 YLR222C S000004212 YLR222C RiBi 
C4_06790W_A  CAL0000198582 GPN3 YLR243W S000004233 YLR243W RiBi 
C5_01580C_A CEF3 CAL0000190871 YEF3 YLR249W S000004239 YLR249W RiBi 
C5_01980C_A  CAL0000197371 SSP120 YLR250W S000004240 YLR250W iESR 
C2_06430C_A  CAL0000199251 SYM1 YLR251W S000004241 YLR251W iESR 
C7_00710W_A RPS28B CAL0000196464 RPS28B YLR264W S000004254 YLR264W RP 
C7_01190W_A  CAL0000181791 DCS1 YLR270W S000004260 YLR270W iESR 
C6_01890C_A  CAL0000180288 DBP9 YLR276C S000004266 YLR276C RiBi 
C7_00300W_A  CAL0000175025 YLR290C YLR290C S000004281 YLR290C iESR 
C2_03990W_A GCD7 CAL0000187213 GCD7 YLR291C S000004282 YLR291C RiBi 
C2_06310C_A GSP1 CAL0000182095 GSP1 YLR293C S000004284 YLR293C RiBi 
C1_00550W_A CIS2 CAL0000184736 ECM38 YLR299W S000004290 YLR299W iESR 
C2_00210W_A RPL38 CAL0000195876 RPL38 YLR325C S000004317 YLR325C RP 
C2_00250W_A STF2 CAL0000185307 TMA10 YLR327C S000004319 YLR327C iESR 
C5_03540C_A RPS25B CAL0000173943 RPS25B YLR333C S000004325 YLR333C RP 
CR_03650W_A SGD1 CAL0000199737 SGD1 YLR336C S000004328 YLR336C RiBi 
C7_00990W_A RPP0 CAL0000189629 RPP0 YLR340W S000004332 YLR340W RP 
C1_02320C_A  CAL0000179837 YLR345W YLR345W S000004337 YLR345W iESR 
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C6_01140C_A ARC18 CAL0000196412 ARC18 YLR370C S000004362 YLR370C iESR 
C2_03230C_A FEN12 CAL0000193175 ELO3 YLR372W S000004364 YLR372W RiBi 
CR_08480C_A  CAL0000180472 RPS29A YLR388W S000004380 YLR388W RP 
CR_08590W_A  CAL0000185208 AFG2 YLR397C S000004389 YLR397C RiBi 
C2_02420C_A  CAL0000188545 DUS3 YLR401C S000004393 YLR401C RiBi 
C5_00290W_A DUS4 CAL0000191650 DUS4 YLR405W S000004397 YLR405W RiBi 
C2_05410W_A  CAL0000188731 RPL31B YLR406C S000004398 YLR406C 
SGD-annotated 
RP 
C2_02430W_A UTP21 CAL0000192006 UTP21 YLR409C S000004401 YLR409C RiBi 
C5_00250C_A  CAL0000178313 BER1 YLR412W S000004404 YLR412W RiBi 
C1_03060C_A TSR2 CAL0000185349 TSR2 YLR435W S000004427 YLR435W RiBi 
C4_00020W_A  CAL0000178095 VMA6 YLR447C S000004439 YLR447C RiBi 
C1_03110W_A RPL6 CAL0000181737 RPL6B YLR448W S000004440 YLR448W RP 
C1_00500C_A GLO1 CAL0000175730 GLO1 YML004C S000004463 YML004C iESR 
C3_06420C_A  CAL0000179869 YML018C YML018C S000004480 YML018C RiBi 
C2_01430W_A APT1 CAL0000192887 APT1 YML022W S000004484 YML022W RP 
C7_00960W_A RPS18 CAL0000197056 RPS18B YML026C S000004488 YML026C RP 
C4_02020W_A CAT2 CAL0000184947 CAT2 YML042W S000004506 YML042W iESR 
CR_06480C_A RRN11 CAL0000185586 RRN11 YML043C S000004507 YML043C RiBi 
C2_06390C_A IMH3 CAL0000175344 IMD4 YML056C S000004520 YML056C RiBi 
C7_03910W_A OGG1 CAL0000183658 OGG1 YML060W S000004525 YML060W RiBi 
C1_03090W_A RPS1 CAL0000192592 RPS1B YML063W S000004528 YML063W RP 
C2_09500W_A  CAL0000188810 DUS1 YML080W S000004545 YML080W RiBi 
CR_09800C_A  CAL0000180872 UTP14 YML093W S000004558 YML093W RiBi 
CR_01650W_A URA5 CAL0000176894 URA5 YML106W S000004574 YML106W RiBi 
C2_05470W_A COQ5 CAL0000175801 COQ5 YML110C S000004578 YML110C iESR 
CR_09140C_A  CAL0000184548 MSC1 YML128C S000004597 YML128C iESR 
C2_05130W_A  CAL0000187542 YML131W YML131W S000004600 YML131W iESR 
CR_00680W_A BUD22 CAL0000194312 BUD22 YMR014W S000004616 YMR014W RiBi 
C4_00380W_A  CAL0000175239 ARA2 YMR041C S000004644 YMR041C iESR 
C1_04130W_A ERB1 CAL0000194713 ERB1 YMR049C S000004652 YMR049C RiBi 
C5_00480C_A SEC14 CAL0000199482 SEC14 YMR079W S000004684 YMR079W RiBi 
CR_00090C_A  CAL0000190190 YMR090W YMR090W S000004696 YMR090W iESR 
C2_08670C_A UTP15 CAL0000175436 UTP15 YMR093W S000004699 YMR093W RiBi 
CR_02820W_A PGM2 CAL0000201506 PGM2 YMR105C S000004711 YMR105C iESR 
C1_00410C_A  CAL0000181570 HFD1 YMR110C S000004716 YMR110C iESR 
C7_01250W_A ASC1 CAL0000180554 ASC1 YMR116C S000004722 YMR116C RP 
CR_04100C_A RPL15A CAL0000190553 RPL15B YMR121C S000004728 YMR121C RP 
C2_00410C_A  CAL0000195316 ECM16 YMR128W S000004735 YMR128W RiBi 
C1_12680W_A  CAL0000198380 RRB1 YMR131C S000004738 YMR131C RiBi 
C2_02530W_A  CAL0000198820 GAT2 YMR136W S000004744 YMR136W iESR 
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C2_04290W_A RIM11 CAL0000186692 RIM11 YMR139W S000004747 YMR139W iESR 
C1_03030W_A RPS16A CAL0000175363 RPS16A YMR143W S000004751 YMR143W RP 
C1_02790W_A TIF34 CAL0000192484 TIF34 YMR146C S000004754 YMR146C RP 
C4_04250W_A  CAL0000193728 YMR155W YMR155W S000004764 YMR155W iESR 
C2_09220W_A DDR48 CAL0000176590 DDR48 YMR173W S000004784 YMR173W iESR 
C2_03960W_A RPL39 CAL0000177209 RPL36A YMR194W S000004807 YMR194W RP 
C3_03410C_A  CAL0000188430 YMR196W YMR196W S000004809 YMR196W iESR 
C3_03400C_A VTI1 CAL0000188283 VTI1 YMR197C S000004810 YMR197C iESR 
C1_09360C_A  CAL0000200870 EFR3 YMR212C S000004825 YMR212C RiBi 
C1_09490C_A GUA1 CAL0000179678 GUA1 YMR217W S000004830 YMR217W RiBi 
C2_02540W_A  CAL0000188474 RRP5 YMR229C S000004842 YMR229C RiBi 
C6_03260W_A  CAL0000187941 RNH1 YMR234W S000004847 YMR234W RiBi 
C3_01990W_A RNA1 CAL0000191775 RNA1 YMR235C S000004848 YMR235C RiBi 
C4_04830W_A DCR1 CAL0000189883 RNT1 YMR239C S000004852 YMR239C RiBi 
C2_02200W_A  CAL0000192596 ZRC1 YMR243C S000004856 YMR243C RiBi 
C1_11660W_A GAD1 CAL0000195622 GAD1 YMR250W S000004862 YMR250W iESR 
CR_01710W_A  CAL0000189317 TMA23 YMR269W S000004882 YMR269W RiBi 
C3_07460W_A  CAL0000184913 FCP1 YMR277W S000004890 YMR277W RiBi 
C5_04750C_A HAS1 CAL0000175982 HAS1 YMR290C S000004903 YMR290C RiBi 
C3_04550C_A CMK1 CAL0000190479 TDA1 YMR291W S000004905 YMR291W iESR 
C7_03360W_A CPY1 CAL0000177922 PRC1 YMR297W S000004912 YMR297W iESR 
CR_03620C_A  CAL0000182841 YME2 YMR302C S000004917 YMR302C iESR 
C2_10050W_A  CAL0000182786 UBP15 YMR304W S000004920 YMR304W iESR 
C1_00220W_A PHR2 CAL0000181783 GAS1 YMR307W S000004924 YMR307W RiBi 
C1_08110W_A  CAL0000200179 PSE1 YMR308C S000004925 YMR308C RiBi 
C4_01490W_A NIP1 CAL0000176830 NIP1 YMR309C S000004926 YMR309C RiBi 
C4_02260C_A  CAL0000191193 YMR310C YMR310C S000004927 YMR310C RiBi 
C6_02560W_A  CAL0000178081 YMR315W YMR315W S000004932 YMR315W iESR 
CR_03070W_A DOM34 CAL0000193423 DOM34 YNL001W S000004946 YNL001W RiBi 
CR_06120W_A RPL7 CAL0000194902 RLP7 YNL002C S000004947 YNL002C RP 
C2_07140W_A  CAL0000187183 YNL010W YNL010W S000004955 YNL010W RiBi 
CR_02030C_A  CAL0000178878 RCM1 YNL022C S000004967 YNL022C RiBi 
C1_04100C_A POR1 CAL0000182381 POR1 YNL055C S000005000 YNL055C iESR 
CR_04170W_A  CAL0000190202 NOP2 YNL061W S000005005 YNL061W RiBi 
CR_04160C_A  CAL0000185106 GCD10 YNL062C S000005006 YNL062C RiBi 
C6_00820W_A SUN41 CAL0000175157 SUN4 YNL066W S000005010 YNL066W RiBi 
C3_02470C_A RPL9B CAL0000184881 RPL9B YNL067W S000005011 YNL067W RP 
CR_07950W_A IMP4 CAL0000181923 IMP4 YNL075W S000005019 YNL075W RiBi 
C3_04300C_A POL1 CAL0000174261 POL1 YNL102W S000005046 YNL102W RiBi 
C7_00690W_A NOP15 CAL0000196813 NOP15 YNL110C S000005054 YNL110C RiBi 
CR_02520W_A RPC19 CAL0000179133 RPC19 YNL113W S000005057 YNL113W RiBi 
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C6_00250W_A  CAL0000196053 YNL115C YNL115C S000005059 YNL115C iESR 
CR_03550W_A NCS2 CAL0000189560 NCS2 YNL119W S000005063 YNL119W RP 
CR_04110W_A  CAL0000196049 NAF1 YNL124W S000005068 YNL124W RiBi 
CR_04240C_A  CAL0000178904 KRE33 YNL132W S000005076 YNL132W RiBi 
CR_03300C_A  CAL0000183745 YNL134C YNL134C S000005078 YNL134C iESR 
C2_06970W_A AAH1 CAL0000194200 AAH1 YNL141W S000005085 YNL141W RiBi 
CR_02720C_A RPC31 CAL0000174952 RPC31 YNL151C S000005095 YNL151C RiBi 
C4_05860W_A  CAL0000198712 GIM3 YNL153C S000005097 YNL153C RiBi 
C1_10390C_A RPL42 CAL0000190451 RPL42A YNL162W S000005106 YNL162W RP 
C1_07140C_A RIA1 CAL0000176174 RIA1 YNL163C S000005107 YNL163C RiBi 
C3_07300W_A NOP13 CAL0000196304 NOP13 YNL175C S000005119 YNL175C RiBi 
CR_04810W_A RPS3 CAL0000200765 RPS3 YNL178W S000005122 YNL178W RP 
C1_06760C_A  CAL0000201524 IPI3 YNL182C S000005126 YNL182C RiBi 
C1_06780W_A NPR1 CAL0000199299 NPR1 YNL183C S000005127 YNL183C iESR 
C4_03440C_A DOT4 CAL0000187993 UBP10 YNL186W S000005130 YNL186W RiBi 
C1_02220C_A  CAL0000191549 YNL200C YNL200C S000005144 YNL200C iESR 
C3_05710W_A RCT1 CAL0000178441 YNL208W YNL208W S000005152 YNL208W iESR 
CR_08090W_A SSB1 CAL0000194973 SSB2 YNL209W S000005153 YNL209W RP 
CR_03240C_A  CAL0000195354 JJJ1 YNL227C S000005171 YNL227C RiBi 
C1_08980C_A ZWF1 CAL0000192089 ZWF1 YNL241C S000005185 YNL241C iESR 
C1_13030C_A  CAL0000188986 YNL247W YNL247W S000005191 YNL247W RiBi 
C2_01070W_A  CAL0000186371 RPA49 YNL248C S000005192 YNL248C RiBi 
C5_01910W_A GIS2 CAL0000183688 GIS2 YNL255C S000005199 YNL255C RiBi 
C5_00770C_A FOL1 CAL0000194395 FOL1 YNL256W S000005200 YNL256W RiBi 
C1_02980W_A GOR1 CAL0000192040 GOR1 YNL274C S000005218 YNL274C iESR 
C5_01180W_A PUS4 CAL0000191725 PUS4 YNL292W S000005236 YNL292W RiBi 
CR_06560C_A  CAL0000175245 BXI1 YNL305C S000005249 YNL305C iESR 
C3_02350W_A  CAL0000194501 KRI1 YNL308C S000005252 YNL308C RiBi 
C2_10740C_A  CAL0000193421 EMW1 YNL313C S000005257 YNL313C RiBi 
CR_03500W_A CIT1 CAL0000197786 CIT1 YNR001C S000005284 YNR001C iESR 
C2_06680W_A FRP3 CAL0000177981 ATO2 YNR002C S000005285 YNR002C iESR 
C6_03210C_A  CAL0000189174 RPC34 YNR003C S000005286 YNR003C RiBi 
C1_00070W_A MVD CAL0000181620 MVD1 YNR043W S000005326 YNR043W RiBi 
C6_03640W_A NOG2 CAL0000182741 NOG2 YNR053C S000005336 YNR053C RiBi 
C5_02070C_A  CAL0000181506 ESF2 YNR054C S000005337 YNR054C RiBi 
C7_02930C_A  CAL0000182014 TSR4 YOL022C S000005382 YOL022C RiBi 
CR_08360C_A RPP2A CAL0000175968 RPP2A YOL039W S000005399 YOL039W RP 
C3_04670C_A RPS15 CAL0000179139 RPS15 YOL040C S000005400 YOL040C RP 
C2_04120C_A  CAL0000199505 NOP12 YOL041C S000005401 YOL041C RiBi 
CR_08380C_A  CAL0000201421 RRT8 YOL048C S000005408 YOL048C iESR 
C1_12310C_A CSI2 CAL0000186593 BRX1 YOL077C S000005437 YOL077C RiBi 
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C2_08140C_A PHM7 CAL0000191215 PHM7 YOL084W S000005444 YOL084W iESR 
C1_12380C_A WRS1 CAL0000182691 WRS1 YOL097C S000005457 YOL097C RiBi 
C3_05100C_A RPL18 CAL0000188970 RPL18A YOL120C S000005480 YOL120C RP 
C3_05200W_A RPS19A CAL0000200926 RPS19A YOL121C S000005481 YOL121C RP 
C3_05140C_A  CAL0000185296 TRM11 YOL124C S000005484 YOL124C RiBi 
C6_01970C_A RPL25 CAL0000200350 RPL25 YOL127W S000005487 YOL127W RP 
C6_03240W_A  CAL0000179051 GRE2 YOL151W S000005511 YOL151W iESR 
C1_05050C_A RRP6 CAL0000183418 RRP6 YOR001W S000005527 YOR001W RiBi 
CR_02420W_A  CAL0000197728 UTP23 YOR004W S000005530 YOR004W RiBi 
C2_03130W_A  CAL0000176044 SFM1 YOR021C S000005547 YOR021C RiBi 
C2_02920W_A  CAL0000185278 TMC1 YOR052C S000005578 YOR052C iESR 
C2_09430W_A RPL3 CAL0000201023 RPL3 YOR063W S000005589 YOR063W RP 
C3_01480C_A RKI1 CAL0000188418 RKI1 YOR095C S000005621 YOR095C RiBi 
C3_01490W_A RPS7A CAL0000199878 RPS7A YOR096W S000005622 YOR096W RP 
CR_10410C_A  CAL0000173996 PNO1 YOR145C S000005671 YOR145C RiBi 
C1_00310W_A  CAL0000201857 PNS1 YOR161C S000005687 YOR161C iESR 
C7_00550C_A GLN4 CAL0000198388 GLN4 YOR168W S000005694 YOR168W RiBi 
CR_03770C_A RPS30 CAL0000193815 RPS30B YOR182C S000005708 YOR182C RP 
C1_03710C_A MSB1 CAL0000199709 MSB1 YOR188W S000005714 YOR188W RiBi 
CR_05520W_A NOC2 CAL0000192871 NOC2 YOR206W S000005732 YOR206W RiBi 
C7_04040C_A NPT1 CAL0000174810 NPT1 YOR209C S000005735 YOR209C RiBi 
C4_03040W_A  CAL0000183011 RPB10 YOR210W S000005736 YOR210W RiBi 
C2_05790C_A RFC1 CAL0000180025 RFC1 YOR217W S000005743 YOR217W RiBi 
C7_01700W_A  CAL0000179241 RCN2 YOR220W S000005746 YOR220W iESR 
CR_04780W_A RPB8 CAL0000181508 RPB8 YOR224C S000005750 YOR224C RiBi 
C2_10270W_A PUS7 CAL0000177714 PUS7 YOR243C S000005769 YOR243C RiBi 
C1_09330W_A  CAL0000197859 TMA16 YOR252W S000005778 YOR252W RiBi 
CR_04070W_A NAT5 CAL0000188442 NAT5 YOR253W S000005779 YOR253W RiBi 
CR_03990C_A GCD1 CAL0000190232 GCD1 YOR260W S000005786 YOR260W RiBi 
C1_09470C_A  CAL0000177270 FSF1 YOR271C S000005797 YOR271C RiBi 
C1_09510W_A YTM1 CAL0000176486 YTM1 YOR272W S000005798 YOR272W RiBi 
C1_09350W_A  CAL0000199949 CAF20 YOR276W S000005802 YOR276W RiBi 
CR_07030C_A  CAL0000179560 RRP36 YOR287C S000005813 YOR287C RiBi 
C2_00770W_A  CAL0000200626 YOR289W YOR289W S000005815 YOR289W iESR 
C2_08040C_A RPS10 CAL0000177647 RPS10A YOR293W S000005819 YOR293W RP 
C1_00900W_A RRS1 CAL0000188560 RRS1 YOR294W S000005820 YOR294W RiBi 
C6_00370C_A NOP5 CAL0000190357 NOP58 YOR310C S000005837 YOR310C RiBi 
C4_01520C_A RPL20B CAL0000200399 RPL20B YOR312C S000005839 YOR312C RP 
C7_01450C_A PRT1 CAL0000183631 PRT1 YOR361C S000005888 YOR361C RiBi 
C3_07150C_A RPS12 CAL0000200890 RPS12 YOR369C S000005896 YOR369C RP 
C1_04680W_A PIL1 CAL0000179346 LSP1 YPL004C S000005925 YPL004C iESR 
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C1_11650W_A EGD1 CAL0000174763 EGD1 YPL037C S000005958 YPL037C RiBi 
C1_04390C_A NOP4 CAL0000184653 NOP4 YPL043W S000005964 YPL043W RiBi 
C3_06040W_A  CAL0000176267 LEE1 YPL054W S000005975 YPL054W iESR 
C3_06060W_A ELP3 CAL0000193262 ELP3 YPL086C S000006007 YPL086C RiBi 
C4_07050W_A YDC1 CAL0000177800 YDC1 YPL087W S000006008 YPL087W iESR 
C4_01270W_A RPS6A CAL0000181351 RPS6A YPL090C S000006011 YPL090C RP 
C7_01790C_A RPL5 CAL0000178607 RPL5 YPL131W S000006052 YPL131W 
SGD-annotated 
RP 
C2_05710C_A  CAL0000183633 RPL33A YPL143W S000006064 YPL143W RP 
C2_05750W_A  CAL0000191069 NOP53 YPL146C S000006067 YPL146C RiBi 
C3_03830W_A  CAL0000193039 RRD2 YPL152W S000006073 YPL152W iESR 
C2_07400C_A 01-Apr CAL0000197684 PEP4 YPL154C S000006075 YPL154C iESR 
CR_01690C_A CDC60 CAL0000201312 CDC60 YPL160W S000006081 YPL160W RiBi 
C1_02080W_A SET6 CAL0000174725 SET6 YPL165C S000006086 YPL165C iESR 
C6_04530C_A  CAL0000188018 RTT10 YPL183C S000006104 YPL183C RiBi 
C3_02540C_A OXR1 CAL0000197295 OXR1 YPL196W S000006117 YPL196W iESR 
C2_07210C_A TPK2 CAL0000181882 TPK2 YPL203W S000006124 YPL203W iESR 
C6_02290C_A  CAL0000201526 TYW1 YPL207W S000006128 YPL207W RiBi 
C6_02360W_A NIP7 CAL0000185986 NIP7 YPL211W S000006132 YPL211W RiBi 
C6_02350C_A  CAL0000183350 PUS1 YPL212C S000006133 YPL212C RiBi 
C3_01000W_A BMS1 CAL0000199005 BMS1 YPL217C S000006138 YPL217C RiBi 
C6_02240C_A RPL10A CAL0000174170 RPL1A YPL220W S000006141 YPL220W RP 
CR_09370W_A ELF1 CAL0000177541 NEW1 YPL226W S000006147 YPL226W RiBi 
CR_06440C_A BCR1 CAL0000177853 USV1 YPL230W S000006151 YPL230W iESR 
C7_01810W_A RVB2 CAL0000176498 RVB2 YPL235W S000006156 YPL235W RiBi 
C7_04130C_A SUI3 CAL0000188940 SUI3 YPL237W S000006158 YPL237W RiBi 
C1_13720W_A  CAL0000187064 KEL3 YPL263C S000006184 YPL263C RiBi 
C1_13730C_A DIM1 CAL0000196194 DIM1 YPL266W S000006187 YPL266W RiBi 
C1_08410C_A SAM4 CAL0000183325 SAM4 YPL273W S000006194 YPL273W RiBi 
C7_00570W_A RPA135 CAL0000201405 RPA135 YPR010C S000006214 YPR010C RiBi 
CR_07080W_A  CAL0000186684 TIF6 YPR016C S000006220 YPR016C RiBi 
C1_06940C_A ATC1 CAL0000186706 ATH1 YPR026W S000006230 YPR026W iESR 
C5_05490C_A HTS1 CAL0000190585 HTS1 YPR033C S000006237 YPR033C RiBi 
C1_03310W_A  CAL0000201344 ARP7 YPR034W S000006238 YPR034W RiBi 
C5_02490C_A TIF5 CAL0000179125 TIF5 YPR041W S000006245 YPR041W RiBi 
C5_04590C_A RPL43A CAL0000185522 RPL43A YPR043W S000006247 YPR043W RP 
C1_11500C_A ARO7 CAL0000179531 ARO7 YPR060C S000006264 YPR060C RiBi 
C3_06900W_A ISA2 CAL0000191195 ISA2 YPR067W S000006271 YPR067W iESR 
C1_08320W_A TKL1 CAL0000174068 TKL1 YPR074C S000006278 YPR074C RiBi 
C2_08370C_A TEF1 CAL0000196936 TEF1 YPR080W S000006284 YPR080W RiBi 
C1_13190W_A  CAL0000182808 YPR098C YPR098C S000006302 YPR098C iESR 
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C2_05340C_A RPC40 CAL0000195273 RPC40 YPR110C S000006314 YPR110C RiBi 
C3_02020W_A  CAL0000192627 MRD1 YPR112C S000006316 YPR112C RiBi 
C2_01160W_A  CAL0000191452 MRI1 YPR118W S000006322 YPR118W RiBi 
C1_06580W_A RPS23A CAL0000197722 RPS23B YPR132W S000006336 YPR132W RP 
CR_02710W_A RRP9 CAL0000183718 RRP9 YPR137W S000006341 YPR137W RiBi 
C2_09380W_A RRP15 CAL0000177236 RRP15 YPR143W S000006347 YPR143W RiBi 
C2_07340W_A NOC4 CAL0000199787 NOC4 YPR144C S000006348 YPR144C RiBi 
C3_04910C_A NCE102 CAL0000190917 NCE102 YPR149W S000006353 YPR149W iESR 
C6_01630W_A TIF3 CAL0000196640 TIF3 YPR163C S000006367 YPR163C RiBi 
C1_08870C_A JIP5 CAL0000174164 JIP5 YPR169W S000006373 YPR169W RiBi 
C4_05140C_A GDB1 CAL0000189511 GDB1 YPR184W S000006388 YPR184W iESR 
C5_03360W_A RPO26 CAL0000199338 RPO26 YPR187W S000006391 YPR187W RiBi 
CR_02890C_A  CAL0000174854 RPC82 YPR190C S000006394 YPR190C RiBi 
 
Supplemental  Table  5.  S.  cerevisiae  ESR  ortholog  genes  in  C.albicans.  RP(Ribosomal 
Protein),  RiBi(Ribosome  Biogenesis),  iESR(involved  in  Environmental   Stress  Response) 
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